Extracorporeal shock wave lithotripsy for urinary calculi by Bierkens, A.F.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/114000
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
Extracorporeal 
Shock Wave 
Lithotripsy 
For Urinary Calculi 
ш 

Extracorporeal shock wave lithotripsy for urinary calculi 

Extracorporeal 
Shock Wave 
Lithotripsy 
For Urinary Calculi 
Een wetenschappelijke proeve op het gebied van 
de Medische Wetenschappen in het bijzonder de Geneeskunde 
Proefschrift ter verkrijging van de graad van doctor aan de Katholieke Universiteit 
Nijmegen, volgens besluit van het College van Decanen 
in het openbaar te verdedigen op donderdag 24 oktober 1991 
des namiddags te 1.30 uur precies 
door 
ALEXANDER FRANS BIERKENS 
geboren 22 december 1961, te Nijmegen 
promotor: Prof. Dr. EM.J. Debruyne 
co-promotor: Dr. A.J.M. Hendrikx 
aan: Yasmine 
Jeanine 
Xavier 
Mijn ouders 
Financial support by Siemens Nederland, Astra Pharmaceutica and Merck Sharp & 
Dohme is greatfully acknowledged 
CIP-DATA KONINKLIJKE BIBLIOTHEEK, DEN HAAG 
Bierkens, Alexander Frans 
Extracorporeal shock wave lithotripsy for urinary calculi / Alexander Frans Bierkens. 
- [S.I. : s.п.] Thesis Nijmegen, 1991. - With summary in Dutch 
ISBN 90-9004480-9 
Subject headings: niersteenvergruizing, urolithiasis, urology 
No part of this book may be reproduced by any mechanical, photographic or electro­
nic process, or in the form of phonographic recording, nor may it be stored in a 
retrievalsystem, transmitted, or otherwise copied for public or private use, without 
the written permission of the author. 
Vormgeving: Anky ter Beek, Nijmegen 
Opmaak: Medioeval, Nijmegen 
Druk: ss Ν, Nijmegen 
ISBN 90 9004480 9 
Contents 
ι 
General introduction, ç 
2 
Outline of the thesis, iff 
3 
Extracorporeal shock wave lithotripsy for large renal calculi. The role of ureteral 
stents. A randomized trial. 2} 
4 
Extracorporeal shock wave lithotripsy for small symptomatic renal calculi. Is it effec-
tive? # 
5 
Treatment of symptomatic calyceal diverticula calculi; Extracorporeal shock wave li-
thotripsy versus percutaneous nephrolitholapaxy. 43 
6 
Treatment of proximal and midureteral calculi: a randomized trial of in situ and 
pushback extracorporeal lithotripsy, j j 
7 
Extracorporeal shock wave lithotripsy of calculi in the lower third of the ureter; rando-
mized comparison of in situ treatment versus treatment with a loop catheter. 6j 
8 
The use of local anaesthesia in second generation extracorporeal shock wave litho-
tripsy; Eutectic Mixture of Local Anaesthetics. 75 
9 
The role of extracorporeal shock wave lithotripsy in the treatment of urolithiasis in 
children. 8} 
10 
Efficacy of second generation lithotripters. A multicenter comparative study of 2206 
ESWL treatments with the Siemens Lithostar, Dornier HM4, Wolf Piezolith 2300, 
Direx Tripter x-i and Breakstone lithotripter. ç} 
Summary and conclusions. ιο$ 
Samenvatting en conclusies, ni 
Dankwoord, η/ 
Curriculum vitae. np 
CHAPTER I 
General introduction 

General introduction 
Urinary calculi can occur in the renal parenchyma, renal collecting system, ureter, 
bladder, prostate and urethra. Urolithiasis is the third most common affliction of the 
urinary tract and typically occurs in middle life, during a person's most productive 
years. It is estimated that at least 5 per cent of the female and 12 per cent of the male 
population will have had one episode of renal colic from a kidney stone by the age of 
70 years '. 
Urolithiasis causes pain, loss of work time, medical expense and the need for hos­
pitalization, but is not usually the cause of renal failure. It can, however, result in re­
duced kidney function when it is accompanied by a urinary tract infection or ob­
struction '. 
Etiological factors involved in the formation of stones within the urinary tract in­
clude ion-supersaturation, reduced urinary inhibitors and urinary particle retention2. 
The incidence of urolithiasis in the Netherlands is 70 - 75 out of 100.000 persons3. 
Before 1980, symptomatic urolithiasis was treated by means of open operations. 
The introduction of Extracorporeal Shock Wave Lithotripsy, in 1980, constituted 
a major breakthrough in the management of urinary calculi. 
Brief historical overview 
Urolithiasis seems to have occurred since the beginning of mankind. Urinary calculi 
have been identified in the mummies of ancient Egypt and they were probably fre­
quent, as can be deduced from references to bloody urine in old papyri4. 
In the Hippocratic oath, doctors are advised to leave the treatment of urinary cal­
culi to skilled specialists. 
Stone surgery goes back at least 2000 years 5. In the ancient India of 600 ВС there 
already existed descriptions of operative methods for many different abnormal states, 
including bladder stones. The development of surgery in Europe derived from Greek 
and Byzantine traditions and was limited to wound fractures, dislocations, amputa­
tions and the opening of abscesses4. 
During the Middle Ages two groups of surgeons began to emerge. One group was 
made of those who had received further education in the medical field and the other 
group consisted of 'barber' surgeons: untutored wound doctors, who apparently op­
erated on bladder stones with results that were so bad that reputable surgeons avoided 
being associated with them 4. 
Until the 19th century, surgery only made very slow steps forward. It was held 
back by lack of effective means of controlling pain and the devastating effects of post­
operative infection. Once anaesthesia had become common and new kinds of instru­
ments began to be devised, surgical procedures multiplied and in the ith century sur­
geons began to specialize in the field of Urology. Lithotripsy was developed in the 
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I9th century to counter the high mortality rate for open operations for bladder 
stonese'. The first recorded lithotripsy on a living patient was performed in Paris, in 
1824, by Civiale, who used a stiff metal tubular devise that was passed through the 
urethra in order to crush bladder stones blindly7. 
Approximately 100 years ago bladder stones became less frequent while the inci-
dence of upper urinary tract calculi increased. This was due to a change in diet ( an 
increased intake of animal proteins, e.g. milk ), to improved conditions of hygiene 
and a higher standard of living. Up to World War II the treatment of renal calculi 
often consisted of nephrectomy5. A more thorough knowledge of the renal anatomy 
later made more precise surgical approaches possible and also reduced morbidity 8. 
Surgery remained the preferred method of treatment for renal calculi until the 
1980s. Open operations produced favourable results - in 80 to 90% of all operations it 
was possible to achieve the total removal of all macroscopic stone - but were accompa-
nied by a high rate of post-operative pneumonia, infection, pain and bodily disfigure-
ment s. With the introduction of methods for percutaneous access to the kidney, the 
role of open surgery decreased. In 1976 the first percutaneous tract was established 
that was specifically intended for the removal of a stone9. 
The technique of percutaneous access made it possible for renal and ureteral 
stones to be removed directly and through a variety of methods (ultrasound, electro-
hydraulic lithotripsy and mechanical crushing) '0. Although percutaneous surgery is 
highly effective - successful removal of the targeted renal stone may be expected in up 
to 98 per cent of all cases - it is an invasive procedure and susceptible to complications 
such as post-operative bleeding and urosepsis ". Nevertheless, it was an improvement 
on open operations. 
The introduction of Extracorporeal Shock Wave Lithotripsy (ESWL) has brought 
about a revolutionary change in the management of urinary tract calculi. 
Until the early 1970's, the use of shock waves in medicine had not been considered 
possible, but Schmiedt, Eisenberger and Chaussy from the urological center of the 
University of Munich recognized the significance of the idea and, in collaboration 
with the Dornier company, they turned it into a medically applicable reality. In 1974 
they started a research project,2. 
In 1976, after extensive in vitro testing, the first experiments on animals were car-
ried out and it was proved that shock waves generated outside the body could non-in-
vasively disintegrate kidney stones I3. Intensive fundamental and experimental re-
search continued until 1980 and resulted in the first successful disintegration of a 
human renal stone by extracorporeally induced shock waves. The shock waves were 
produced by the first lithotripter that was intended for the treatment of human be-
ings, the Dornier HMi I 4 . 
Further developments resulted in a commercially available lithotripter: the 
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Dornier HM3. In 1984, after other German urological centers had reproduced the 
treatment results and demonstrated the reliability of the technology, the Dornier 
HM3 was installed in the United States. 
Since that time, ESWL has been the most frequently used method for treating uri-
nary tract calculi. 
Extracorporeal shock wave lithotripsy 
Technical aspects and principles 
Shock waves are characterized by a single pressure pulse with a steep onset and gradu-
al decay (Fig. 1). In order to fragment urinary calculi the peak pressure - which is built 
up within a few nanoseconds - should exceed 200 bars ''. 
Shocks are generated in water and travel through the human body because both 
have a similar acoustic impedance. The destructive effect of the shock waves occurs 
when they encounter materials with different acoustic properties, such as brittle 
stones "\ A part of the shock will be reflected and the rest will enter the stone and be 
transmitted through it with a very high pressure front. This results in a very strong 
tensile force 3. Once the tensile force exceeds the solid cohesive strength of the stone, 
the stone will be broken down I7. 
When a shock wave is focused, the pressure that is realised in the focal zone will be 
much higher than elsewhere in the tissue that is transversed by the shock wave. This 
focal zone is defined as the area that contains more than 50% of the pressure maxi-
mum of the focal point. The maximal energy density occurs in the focal point '8. 
Spark gap shock wave generation 
The initial first generation Dornier HM3 Lithotripter generated shock waves by 
means of spark-gap discharge (Fig.i). 
Metal electrodes are placed in the geometric focus of a semi-ellipsoid reflector. High 
voltage discharge of the electrodes causes immediate explosive evaporation and ex-
pansion of the surrounding water which results in the generation of a pressure pulse 
through the surrounding fluid which propagates in all directionsI9. 
The shocks spread circularly and are reflected by the semi-ellipsoid into a second 
focus: the point with the highest energy density. Water is used for transmission of the 
shock wave to the patient and the patient is therefore placed in a water bath. 
Visualisation and positioning of the stone into the shock wave focus is performed by 
fluoroscopy by placing the shockwave focus and the intersection of two X-ray beams 
at the same point. 
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Figure i: Shock wave parameters for successful disintegration 
Electromagnetic shock wave generation 
In electromagnetic shock wave generation (Siemens Lithostar), shocks are generated 
by a pressure wave which is formed when an electrical impulse is applied through a 
slab coil placed in close proximity to an isolated metal membrane 20 (Fig.2). 
1 tlectnc cal 
2 Membrane 
3 Acoustic lens 
4 Coupling be^ows 
5 Shock wave focal point 
6 Shock wave tube water-Ulied 
Figure 2: Electromagnetic shock wave generation 
The electromagnetic field induced by the coil causes the membrane to repel rapidly 
which results in a pressure wave which is propagated through a water- filled tube ". 
The shock waves are applied to the patient via a silicone coupling head which is held 
against the flank. Focusing of the shock waves is accomplished by means of an acous-
tic lens. 
Focusing of the stone is accomplished by means of two standard x-ray units, posi-
tioned in the anteroposterior and oblique planes. 
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Piezoelectric shock wave generation 
The shock wave generator of a piezoelectric lithotripter consists of individual piezoce-
ramic crystals, mounted on a section of a spheric disc22'23. 
By charging them with a high voltage signal, each element generates a unipolar, 
high energy impulse. Because of the shape of the spheric disc, all impulses are focused 
in one point 2 4 (Fig 3). The shock waves are transmitted by degassed water from the 
dish to the patients' body which is partially immersed in a small water bath 25. 
Focusing and localisation of the stone is performed by ultrasound and imaging can be 
performed continuously2б. 
Figure}: Piezoelectric elements mounted on a spheric disc. 
Indications for ESWL 
At the beginning of the ESWL era, treatment by means of this method was limited to 
patients with single renal or calyceal stones of less than 10 mm in diameter. This 
meant that only 20% of all stone patients were considered to be appropriate candi­
dates for ESWL2 7. 
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With the increase in experience in the field of ESWL, the range of indications also 
expanded but there are still several contra-indications for treatment (Table i). 
Table 1. Contra-indications for ESWL. 
Pyelonephritis, Urosepsis 
Pregnancy 
Uncontrolled bleeding disorders 
Obstruction below the calculus 
As ESWL developed, it could also be used in the treatment of larger calculi and 
staghorn calculi. For staghorn calculi, ESWL monotherapy with a preoperative 
Double-J stent showed excellent stone elimination 28-29}0. 
Although 80% of all stones that become symptomatic are ureteral stones, only 10 
to 15 per cent of them require interventional treatment: the remainder pass sponta­
neously '6. Initially, the only ureteral stones to be treated by ESWL were mid- and 
upper ureteral calculi and the treatment was usually carried out after the stone had 
been positioned back into the renal pelvis: the so called push-and-bang technique 
Э М М ) 
There were also urologists who advocated the placement of a Double-J stent be­
side the stone 34'35. Both auxiliary procedures, the push-and-bang technique and the 
Double-J stent, were used to disimpact the ureteral stone and to create an expansion 
chamber around the stone, resulting in a high rate of stone disintegration l6. 
Lower ureteral calculi at first presented problems to the urologist. Focusing and 
positioning of lower ureteral calculi was impossible, mainly due to the technical 
shortcomings of the waterbaths' gantry, but new techniques of positioning made it 
possible for ESWL treatment to become effective in breaking down these calculi as 
well зе''7.з8.э9 i t ¡s estimated that at this moment 80 to 85% of all patients with symp-
tomatic urinary tract calculi can be treated by ESWL 40. 
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Outline of the thesis 
In January 1988, a second generation lithotripter (Siemens Lithostar (fig 1)) was in­
stalled at the stonecenter of the urological clinic of the Radboud University Hospital 
at Nijmegen, The Netherlands. 
Figure ι 
For the treatment of large renal calculi both ESWL monotherapy and ESWL with 
prophylactic ureteral stenting (Double-J stents) are advocated. We were interested to 
find out whether Double-J stents indeed contribute to a more successful treatment 
result for these large renal calculi and therefore performed a randomized trial. (Ch.3). 
lì 
Calculi with a diameter of less than 5 mm often evacuate spontaneously. With new 
lithotripters, however, which makes it superfluous for patients to be hospitalized, the 
threshold for treatment has decreased. We have investigated whether ESWL treat-
ment for such small symptomatic renal calculi is worthwhile. (Ch. 4). 
ESWL is contra-indicated in case of obstruction below the calculus, such as ca-
lyceal diverticula calculi. Both ESWL and percutaneous surgery, however, are advo-
cated as treatment for these calculi. We have compared the results obtained by both 
methods. (Ch.5). 
Ureteral calculi have been subjected to several methods of treatment. For ureteral 
calculi in the upper two thirds of the ureter these methods include in situ treatment, 
ESWL after retrograde manipulation of the stone into the renal collecting system, 
and ESWL of the stone with a stent beside it. Ureteral calculi in the lower third of the 
ureter can be treated in situ or with a loop catheter around the stone. So far, no ran-
domized trials on treatment of ureteral calculi have been reported and therefore we 
conducted two randomized studies, one into the treatment of ureteral calculi in the 
upper two thirds of the ureter (in situ or after retrograde manipulation) and the other 
into the treatment of calculi in the lower third of the ureter (in situ or with a loop 
catheter around the stone). (Chs. 6 & 7). 
ESWL is painful. The skin is one of the areas of the body that is most sensitive to 
the perception of pain. We have investigated the therapeutic efficacy of the use of a 
local anaesthetic cream during ESWL treatment. (Ch.8). 
Urolithiasis in children is uncommon in Western Europe. Stones are often caused 
by anatomic, infectious or metabolic factors. Wc have tried to reach conclusions 
about the role of ESWL in the treatment of urolithiasis in children. (Ch.9). 
The success of the first generation lithotripters has resulted in new, second genera-
tion machines. In order to evaluate their effectiveness a number of urological centers 
have been working together on a comparative study of five different second-genera-
tion lithotripters. (Ch. 10). 
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Abstract 
Ureteral stents reduce complications after extracorporeal shock wave lithotripsy 
(ESWL) and contribute to successful stone passage. However, some reports note 
complications that are attributed to indwelling ureteral stents. We randomized 64 pa­
tients with large renal calculi (stone burden more than 200 mmz.) for in situ treat­
ment or treatment with a prophylactically inserted stent. We used a 6Ch round stent 
with single-coiled ends or a triangular shaped stent with double-coiled ends. Patients 
were treated with a Siemens Lithostar lithotripter. After 3 months, we evaluated the 
results of treatment and post-ESWL morbidity. Of the in situ group (23 patients) 
treatment complications consisted of fever in 3, pyelonephritis in 1 and steinstrasse in 
3. After 3 months, 8 patients (35%) were free of stones. Of the stented population (41 
patients), treatment complications consisted of fever in 7, pyelonephritis in 1, stein­
strasse in 6 and bladder discomfort in almost half of the patients. Stent calcification 
and stent migration were also seen in 7 and 10 patients, respectively. Calcified stents 
had been in situ longer than noncalcified stents. The round stents migrated and calci­
fied more often than the more rigid triangular stents. After 3 months, 18 of the stented 
patients were stone-free (44%). 
We conclude that ureteral stents do not reduce post-ESWL complications. They 
are clearly associated with morbidity and do not improve stone passage markedly. 
Therefore, patients with a stone burden of more than 200 mm2, should be treated in 
situ without auxiliary stenting. 
І 4 
Introduction 
Extracorporeal shock wave lithotripsy (ESWL) has become the preferred treatment 
for renal and ureteral calculi ' , although there are restrictions to its use. For stones 
larger then 3 cm. in diameter percutaneous debulking before ESWL treatment or 
ESWL with prophylactic ureteral stenting is advocated 1 . For complete staghorn cal-
culi good results with ESWL monotherapy combined with prophylactic ureteral 
stenting have been reported ' . The use of Doublc-J stents has proved to contribute to 
successful stone passage 4 and to reduce post-ESWL morbidity 5 but there also have 
been reports of complications that might have been caused by indwelling ureteral 
stents6. 
We have treated more than 1600 patients with a Siemens Lithostar lithotripter. 
Initially we used Double-J stents in all patients with stones larger than 200 mm2. 
However, we noted several complications after ureteral stenting, such as calcification, 
stent migration and patient discomfort; some patients even evacuated the stent spon-
taneously during micturition. 
Therefore, we performed a randomized trial to study the efficacy of prophylactic 
ureteral stenting for the prevention of steinstrasse and to study the complications of 
stenting in ESWL treatment for renal calculi with a stone burden of more than 200 
mm2. 
Material and methods 
From august 1988, 64 consecutive patients between 18 and 83 years old (average age 52 
years) with renal calculi measuring larger than 200 mm2, were randomized on the first 
visit to our outpatient department into 3 groups. One group was treated in situ and 
the others were treated after a ureteral stent had been inserted prophylactically. 
Patients with ureteral stones at the site of treatment were not included. 
We used 2 types of ureteral stents: a 6Ch round stent made of soft polyurethane 
with side holes on the inner side of the single-coiled ends (and a withdrawal string at 
the bladder end) and a 6Ch soft polyurethane Double-J stent with a triangular cross-
section. The triangular cross-section was to improve stone passage beside the s tent 7 . 
The proximal and distal ends were double-coiled to prevent stent migration. Stone 
burden was measured on a plain abdominal x-ray in 2 perpendicular directions. If 
there was more than one calculus total stone surface was measured. 
Before ESWL an excretory urogram was performed and ureteral length was as-
sessed to establish the length of the stent. All patients were treated with a second gen-
eration Siemens Lithostar lithotripter. Stents were placed cystoscopically before 
ESWL on the Lithostar table after informed consent was obtained. AJÍ men random-
ized for treatment with a stent had epidural anaesthesia and the other patients re-
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ceived intravenous analgesia ( maximum o.i mg. fentanyl) and/or intravenous seda­
tion (maximum io mg. diazepam) if necessary. 
Patients were examined ι day, 2 weeks, 1 month and 3 months after treatment. 
Most of the patients were seen in our outpatient department for post-ESWL follow-
up. Data on complications and stone passage were recorded. Physicians who referred 
patients to our department were asked to complete a questionnaire containing all rel­
evant information and to return it 3 months after treatment. After 3 months we evalu­
ated all 64 patients. 
Results 
General data on the patients and the important results are summarized in the table. 
Table 1 Results and number of complications in the three groups of ESWL patients. 
Average age, years 
Stoneburden 
(range) 
No pain or discomfort 
No Fever>38C 
No Pyelonephritis 
No Steinstrasse* 
No Stent migration 
No Incrustation 
No Stonefree after 3 months 
No ESWL sessions per stonefree patient 
In situ 
(n=23) 
55 years 
328 mm 2 
(200 800 mm2) 
3(13%) 
3(13%) 
1 (4%) 
3 (13%) 
-
8 (35%) 
1 4 
Round 
Double-J stent 
(n=24) 
53 years 
318 mm 2 
(200 525 mm2) 
7 (29%) 
2 (8%) 
1 (4%) 
3(13%) 
7 (29%) 
6 (25%) 
10(42%) 
1 4 
Triangular 
Double-J stent 
(n=17) 
46 years 
313 mm 2 
(220 540mm2) 
11 (65%) 
5 (29%) 
0 
3(18%) 
3(18%) 
1 (6%) 
8 (47%) 
1 4 
* Does not include patient with steinst rasse after removal of stent 
** Ρ = 0 65 if nonstented vs stented group 
In situ treatment 
The average stone size in this group was 328 mm2, (range 200 to 800 mm2. ). All 23 
patients received 4000 shocks at 18.1 kV. during the first ESWL treatment. Epidural 
anaesthesia was used in 2 men who were initially randomized for treatment with a 
stent but the stent could not be positioned because of kinking of the lower ureter in 1 
and failure to bypass the stone in the other. During treatment intravenous analgesia 
was used in 5 patients, and intravenous analgesia and sedation were given to another 5 
because of pain caused by the shock waves. 
After ESWL 3 patients complained of intermittent severe pain and renal colic, 
which were caused by passage of stone debris, but analgesics were not required. Post-
ESWL morbidity also included temperature of more than 38C in 2 patients a week 
after treatment and in another after 10 weeks, and 1 patient was rehospitalized because 
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of pyelonephritis. All 3 patients were treated with antibiotics according to the urine 
culture. During routine followup at our outpatient department steinstrasse was seen 
on a plain abdominal x-ray of 3 patients, of whom 1 passed all fragments within a 
week, 1 underwent ureterorenoscopic removal for lower steinstrasse and 1 underwent 
percutaneous removal for upper steinstrasse. No other serious complications were en-
countered in this group. 
Within 3 months 5 patients were completely free of stones after 1 ESWL session 
and 3 after 2 sessions. The over-all percentage free of stones within 3 months was 35%. 
Stent treatment 
We randomized 43 patients for treatment with a Double-J stent. The 27 men and 16 
women had an average stone burden of 316 mm2, (range, 200 to 540 mm2.). At the 
first treatment patients in both groups received an average of 4000 shocks at 18.1 kV. 
Insertion of the stent was unsuccessful in 2 patients. In 1 patient the stent could 
not be placed past the stone and in the other the stent hooked in a kinked lower 
ureter. Consequently, these 2 patients were treated in situ. 
Of the patients randomized for a round stent problems were encountered with the 
pull-out suture in 2, resulting in use of a triangular stent. Of the patients randomized 
for a triangular stent the stent could not be pushed over the guide wire because of 
stiffness in 4 patients, resulting in use of the more flexible round stent. Of 3 men who 
had a urethral stricture, which was encountered during introduction of the cysto-
scope, an Otis urethrotomy was performed in 2 and dilatation of the distal meatus 
was done in 1. Over-all 24 patients had a round Double-J stent and 17 had a triangular 
Double-J stent. 
Anaesthesia 
Insertion of the stent necessitated epidural anaesthesia in 25 men, general anaesthesia 
in 2 men and intravenous sedation in 2 women. During treatment 11 women required 
intravenous analgesia. 
Stent migration 
The stents of 10 patients migrated, which was detected on followup plain abdominal 
x-rays. In 2 cases the stents were directly removed after ESWL. Upward migration was 
seen in 1 man 5 weeks after treatment and the stem was removed ureterorenoscopical-
ly. In the remaining 7 patients stents migrated downward into the ureter 2 to 5 weeks 
after treatment and they were removed in the outpatient department without compli-
cations, including 1 case in which the stent had migrated all the way to the bladder 
(Figure 1). 
The more flexible round stent (7) seemed to be more likely to migrate. 
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Figure ι: Stent which has migrated down to the bladder 
Fever 
Of the triangular stent group 5 patients had fever of more than з80С after ESWL 
treatment. In 3 patients steinstrasse was the origin of the fever, including 1 from 
whom the stent had been removed because stoneburden was considerably reduced 
but steinstrasse occurred. 
Of the round stent group 1 patient was rehospitalized because of pyelonephritis, 
and 2 (rehospitalized) had fever of more than з80С because of a renal hematoma and 
steinstrasse, respectively. 
Steinstrasse 
Despite the Double-J stents, steinstrasse occurred in 6 patients within an average of 4 
weeks after treatment. Additional or auxiliary procedures consisted of ESWL treat­
ment for the obstructing stone in 1 case, ureterorenoscopy for steinstrasse beside a 
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Stent that had migrated upward in i, nephrostomy drainage and ESWL in 2, and re-
moval of the ureteral stones by a sling procedure after the ureteral orifice had been in-
cised in 1. In 1 patient stone debris beside the stent was removed during cystoscopic 
extraction of the stent. Figure 2 shows steinstrasse beside a stent after successful frag-
mentation and figure 3 shows more complex steinstrasse. 
Incrusiation 
Incrustation with calcified material was seen in 7 patients after cystoscopic removal of 
the stents. Although of no consequence in 6 patients, 1 required cystolithotripsy of 
the calcified end that was in the bladder. Stents that were not removed immediately 
after ESWL (2 cases) or after migration (8 cases) were removed within 3 months after 
ESWL. The incrusted stents had been in situ for an average of 10 weeks and the non-
incrustcd stents for 5.5 weeks. Of the 12 round stents 6 and of the 4 triangular stents 1 
that had been in situ for more than 8 weeks were incrusted. 
Discomfort 
Eighteen patients (42%) complained of bladder discomfort for 2 to 9 weeks after 
treatment. Most attributed the pain to the indwelling stents but 4 patients had pain 
after removal of the stents because of the passage of fragments. Removal of stents in 
the outpatient department was painful for most patients. 
Stonefree 
After ESWL 18 patients were free of stones, including 12 after 1 session, 5 after 2 ses-
sions, and 1 after 3 sessions. 
Discussion 
Ureteral stents are used to provide drainage from the kidney to the bladder for various 
reasons, for example when there is an intestinal diversion and when a ureter is ob-
structed by a tumor8 . With the widespread use of ESWL there was evidence that the 
risk of ureteral obstruction after ESWL increased significantly with increasing stone 
size9 .Therefore, ureteral stents were proposed to reduce the morbidity of ESWL 
treatment5. However, ureteral stents are not without complications. 
In a morbidity study Preminger et al recently suggested that ESWL treatment re-
sults after 6 weeks were better for calculi smaller than 3 cm. and patients experienced 
fewer post-ESWL complications if no ureteral stents were used I0 . 
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Figure 2: Large renal calculus Fragmentation after 4000 shocks 
Steinstrasse beside stent Figure 3: Complex steinstrasse 
50 
It is also our impression that one should be reluctant to insert a ureteral stent pro-
phylactically before ESWL treatment in patients whose stones are larger than 200 
mm
2
, in surface area. 
We encountered the first problems during attempted stent placement as interven­
tion for 3 urethral strictures, which was necessary to enable cystoscopic stent inser­
tion. Several other complications and problems also were encountered. 
Stent migration is a well recognized phenomenon " and, therefore, several types of 
stents have been designed. The tip of a stent should prevent migration7. Soft silicone 
stents have the highest incidence of migration compared to stents of polyurethane, 
which has a good memory. Libby et al, using silicone stents, reported an expulsion in­
cidence of 10% s. In our patients in whom polyurethane stents were used stent migra­
tion occurred in about 25% and resulted in premature cystoscopic stent removal be­
cause these stents were no longer serving their purpose. Stents that have migrated 
downward can be removed without problems but those that have migrated upward 
should be removed either ureterorenoscopically or by an open surgical procedure іг. 
We noted with interest that the more rigid triangular stent had a lower tendency to 
migrate than the more flexible round stent which was probably due to the double-
coiled tips at both ends of the triangular stent. 
Stone formation as a complication of indwelling ureteral stents has been reported. 
Spirnak and Resnick recommended that ureteral stents be used with caution in any 
person with a history of stone formation ''. Incrustation of stents with stone material 
occurred in 7 of our patients in whom the stent had been in situ for an average of 
more than 8 weeks. Although it was of no consequence in the majority of patients, in­
crustation can have clinical implications. In 1 of our patient cystolithotripsy of the 
calcified end had to be performed, while others have reported pyelonephritis resulting 
from severe incrustion on ureteral stents 4 . We believe that stents in stone patients 
should be removed within 8 weeks after ESWL treatment. If significant stone frag­
ments persist the stent should be replaced. 
Steinstrasse is a common radiological finding on routine radiograms taken 24 to 
48 hours after lithotripsy, and they usually are transient and asymptomatic '5. We per­
formed invasive treatment in 70% of the steinstrasses that occurred in our study. 
Previous studies suggested that ureteral stents contributed to the successful passage of 
stone fragments in the treatment of large renal calculi 4. We do not share that obser­
vation. In our study steinstrasse occurred in about 15% of the patients with and with­
out stents. However, there might be a difference in the type of steinstrasse with the 
second generation machines compared with the HM3 lithotripter. Boström demon-
strated that the HM3 generates more energy compared with the Siemens Lithostar, 
resulting in more effective stone breaking and smaller stone fragments '6, which may 
lead to "megasteinstrasse" that obstruct the ureter completely with sand particles. The 
use of stents in these situations might result in a milder morbidity and a more pre-
dictable clinical course. Second generation ESWL results in larger fragments which 
might only partially obstruct the ureter and, therefore, cause less morbidity. 
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Distribution of Steinstrasses was equal for round and triangular stents. For treatment 
of large renal calculi several ESWL sessions may be necessary. Large renal calculi 
should be treated in stages to avoid overwhelming passage of stonedebris in the ureter. 
The stone-free rate in our 2 groups (in situ and stent) did not differ significantly ( 
35% versus 44%, P=o.65 chi-square test) and ureteral stents did not appear to con-
tribute to successful stone passage. Patients free of stone underwent an average of 1.4 
ESWL treatments. 
ESWL with a first-generation lithotripter necessitated epidural or general anaes-
thesia '. With the introduction of second-generation lithotripters treatment could be 
performed without anaesthesia on an outpatient basis. However, for insertion of a 
ureteral stent all men needed epidural anaesthesia. 
We conclude that ureteral stents should not be used in patients with large renal cal-
culi, since they do not reduce post-ESWL morbidity, they clearly have morbid effects 
of their own and they do not contribute to successful stone passage after ESWL treat-
ment. 
Therefore, large renal calculi should be treated in situ. Ureteral stents may be nec-
essary in special situations such as in patients with a solitary kidney and to relieve 
proved ureteral obstruction. Double-J stents may also have be beneficial in dilating 
ureters for patients who have relatively small stones and stone burden because after 
stent removal the passage of stones is facilitated. In such cases a triangular stent 
should be used because of its slight tendency to migrate. To prevent incrustation in 
patients with a history of stone disease indwelling ureteral stents should be removed 
or changed within 8 weeks after treatment. ESWL for large calculi, with or without 
stents, may have clear morbidity. 
Lingcman et al postulated that, although stones larger than 2.0 cm. can be treated 
with ESWL, the morbidity appears to be more closely comparable to percutaneous 
techniques I7, which is in accordance with our own experience. Inasmuch as treat-
ment in the in situ group and the stent group was successful in only 35% and 44% of 
the cases, respectively, percutaneous debulking before ESWL should be considered 
for large renal calculi. 
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Vbstract 
lena! calculi with a diameter of less than 5 mm can pass spontaneously. However, 
ome patients have small symptomatic renal calculi for more than three months. We 
¡valuated the results of extracorporeal shock wave lithotripsy in 38 patients with such 
tones. Patients presented with loin pain, hematuria, infection, or a combination of 
:omplaints. The average stone size was 18 mm2. After a wait of 3 months for sponta-
icous evacuation without success, all patients were treated with a Siemens Lithostar 
ithotripter. Three months after treatment, 19 patients (50%) were completely free of 
tones, but seven of them still had complaints; of the 19 patients with residual frag-
nents, eight (42%) were free of complaints. Both evacuation and resolution of com-
jlaints were achieved in only 12 of the 38 patients (32%). We conclude that one 
hould be reluctant to treat small renal calculi, because spontaneous evacuation oc-
:urs in about 80% and the results of ESWT treatment are limited. 
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Introduction 
Since the first success of extracorporeal shock wave lithotripsy (ESWL) was reported 
by Chaussy et al. in 1982 ', it has become the method of treatment for most renal and 
ureteral calculi. 
High success rates were reported of ESWL using the "golden standard" HM3 
lithotripter 2'3. This success contributed to the development of new second- and 
third-generation Hthotripters using different ways of generating shock waves and dif-
ferent imaging techniques. Worldwide, more than 18 types of Hthotripters are now in 
use. The advantages of the second- and third-generation Hthotripters are their lack of 
need for anaesthesia and the ability to treat many patients as outpatients 4·5. 
The decreasing threshold for treatment with ESWL was accompanied by a ten-
dency to treat small symptomatic and asymptomatic renal calculi6 (diameter 5 mm or 
less) that might pass spontaneously 7. We believe that treatment for small asymp-
tomatic renal calculi is not indicated. However, if a patient with a small renal calculus 
presents with symptoms — such as infection, hematuria, or lumbar or abdominal 
pain — treatment of the stone might constitute a cure. Because the operative or per-
cutaneous treatment for those calculi usually can be replaced with anaesthesia-free 
ESWL, one should be motivated to try. The success rate of ESWL in this patient 
group was unknown, so we investigated the effect of ESWL on small symptomatic 
renal calculi. 
Material and methods 
We reviewed the computerized data on 1,600 ESWL patients and selected the cases 
with symptomatic renal calculi smaller than 5 mm in diameter treated at our depart-
ment from January 1988 through October 1989. Only patients with unilateral single 
stones were studied. 
The group consisted of 38 patients (22 men and 16 women) with an average age of 
49 years (range, 20 to 81 years). All had complaints for at least 3 months: flank pain in 
23 (61%), hematuria in three (8%), infection in five (13%) and a combination of com-
plaints in seven (see Table 1). 
Table 1. Complaints of patients 
Complaints Number of patients 
flank pain 23 
hematuria 3 
infection 5 
pain and infection 4 
pain and hematuria 3 
(%) 
61 
8 
13 
11 
8 
In the five patients with only infection as their complaint, a bladder wash-out test ac-
cording to the method of Fairley8 proved that the infection was located in the upper 
urinary tract. 
At the first visit to our outpatient department, an intravenous urogram had been 
made, to exclude calyceal diverticula stones. Before ESWL, a plain x-ray picture was 
taken and stone size (surface area) was measured in two perpendicular directions . Of 
the 38 stones, 20 were in left kidneys and 18 in right kidneys. Stone location is sum-
marized in table 2. 
Table 2. Stone localisation and treatment results. 
Localisation of stones 
Lower calyx 
No of stones 24 
No. (%) of patients stonefree after 3 months 10 (42) 
Middle calyx 
8 
6(75) 
Upper calyx 
6 
4(67) 
During ESWL the patients received an average of 2,045 shocks (range 400 to 4,000) 
at 17.8 kV. All patients were treated in one session. Treatment of 28 patients (74%) 
was on an outpatient basis; 10 (26%) were observed one night after ESWL at the hos-
pital because of auxiliary procedures (n=6) or long travel distances (n=4). All patients 
had prophylactic antibiotics during treatment. If an infection was present, antibiotics 
were given according to the urine culture for at least 5 days. 
For small calculi that could not be seen on fluoroscopy, intravenous contrast 
medium was used (in one patient) to enable focusing on the stone- containing calyx, 
or a radiopacque stent was introduced (in six patients) so that the stone could be 
found near the tip of the stent. Fragmentation was monitored with means of fluo-
roscopy. If fragmentation was seen, a post-ESWL plain x-ray picture was obtained for 
documentation. Patients were seen at our outpatient department, 2, 6, and 12 weeks 
after treatment. Treatment was considered successful if the plain x-ray picture after 12 
weeks showed no residual fragments and the patient was free of complaints. 
Results 
Stone-size (surface area) ranged from 6 to 25 mm2 (average 18 mm1.). Stent placement 
necessitated epidural anaesthesia in six men, and intravenous analgesia (Fentanyl. 
o.oj mg./ml.; maximum 2 ml. ) was given to 15 other patients because of pain caused 
by the shock waves. Seventeen patients needed no anaesthesia at all. 
Complications after treatment consisted of renal colic in three patients (8%), pro-
longed hematuria ( more than 24 hrs) in two (5%) and post-operative fever, which 
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was successfully treated with antibiotics, in one. The average x-ray exposure time was 
2.7 minutes per treatment (range 1.1 to 3.4 minutes). After treatment, fragmentation 
was clearly seen on plain x-ray pictures in 32 patients. The best stone-free results were 
obtained in the 14 patients with middle- and upper-calyceal calculi (stone-free rates 
75% and 67%, respectively; 2x2 table: p=o.i5) (table 2). Of the 24 patients with stones 
in the lower calyx only 42% were stone-free. Only 12 of the 38 patients (32%) became 
free of both stones and complaints, but an additional eight were free of complaints. 
Table 3 presents the 12 week results in relation to history and complaints at the outpa­
tient department. 
Nineteen patients (50%) became stone-free, but complaints persisted in seven of 
them (table 3). 
Of these seven patients, five had presented with pain at the outpatient department; 
two of the five had been operated on years earlier on the same kidney and no explana­
tion for pain was found in the other three. Two of the seven patients, who had pre­
sented with both hematuria and flank pain, complained of persisting pain after 
ESWL, but the hematuria had disappeared; one had carcinophobia related to a previ­
ous nephrectomy due to a renal-cell carcinoma and the other was a psychiatric pa­
tient. 
Of the 12 patients who were stone-free and had no complaints, three had present­
ed at our outpatient department with hematuria, two with infection and seven with 
flank pain. Four had a previous operation on the kidney in question. 
A group of 19 patients had residual fragments, and 11 of them still had complaints. 
Of the 11, six had flanc pain which persisted: three had undergone previous surgery at 
the site of treatment, x-ray pictures revealed severe spondylarthrosis in one, and there 
was no known reason for the pain in two. Three other patients of the π had presented 
initially with pain and urinary tract infection, but were now free of infection and still 
had pain; two had been in car accidents, and one had renal tuberculosis. In the other 
two of the 11 patients with residual fragments and complaints, upper urinary tract in­
fections persisted after ESWL, as proved with a bladder washout test by the method 
of Fairley. 
Eight patients with residual fragments had no complaints after ESWT.. Five had 
presented initially with pain, one with infection, one with pain and infection, and 
one with pain and hematuria. Infection had resolved with antibiotic treatment. 
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Table 3 Follow-up of complaints in the treated population in relation to history and initial complaints at the 
outpatient department (OPD) 
Stonefree after three months (ι 
Complaints at OPD 
Persisting complaints (n= 
Pain 
Hematuria + pain 
No complaints (n=ii) 
Pain 
Hematuria 
Infection 
Not stonefree after three 
Complaints at OPD 
Persisting complaints (n= 
Pain 
Infection 
Pain and 
infection 
No complaints (n»8) 
Pain 
Infection 
Pain + infection 
Pain + hematuria 
-7) 
1=19) 
(n=5) 
(n=2) 
(n=7) 
<Π=)) 
(n=2) 
months (n=i9) 
"III 
(n=6) 
(n=2) 
(n=j) 
(n=5) 
(n=i) 
(n=i) 
(n=i) 
History 
previous operation 
blank 
carcmophobia 
mental reason 
previous operation 
blank 
blank 
previous operation 
blank 
History 
previous operation 
spondylarthrosis 
blank 
blank 
car accident 
tuberculosis 
blank 
blank 
blank 
blank 
(n=2) 
(n=3) 
(n=1) 
(n=1) 
(n=;) 
(n=4) 
(n=,) 
(n=i) 
(n=i) 
(п=з) 
(n=i) 
(n=i) 
(П=2) 
(n=2) 
(n=i) 
(n=5) 
(n=l) 
(n=i) 
(n=l) 
Complaints after ESWL 
pain 
pain 
pain 
pain 
none 
none 
none 
none 
none 
Complaints after ESWL 
pain 
pain 
pain 
infection 
pain 
pain 
none 
none 
none 
none 
Discussion 
Recently, Mee and ThiirofF reported that ESWL can be justified as a noninvasive 
treatment for patients in whom small calyceal stones (smaller than 1 cm) are discov­
ered in the diagnostic evaluation of low back or flank pain 9. The results of our study 
justify that strategy, and we agree that such calculi should be treated with ESWL, be­
cause small obstructing calculi can cause persistent pain ю · " . ESWL is also justified if 
the stones cause hematuria or infection (table 3). Symptomatic calculi less than 5 mm 
in diameter can be expected to pass spontaneously, but many patients, having persis­
tent complaints, will insist on ESWL treatment, especially inasmuch as it can be per-
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formed on an outpatient basis with no or minimal anaesthesia I2'13. Therefore, if 
symptomatic stones do not pass spontaneously within 3 months, the urologist might 
be tempted to use ESWL, but there is a possibility of overtreatment with the unneces­
sary risks related to high-energy shock wavesI4'15. 
In our patient population, only 19 (50%) of the patients were free of stones 3 
months after ESWL, but seven of the 19 still had pain complaints; obviously the 
stones had not been the cause of pain. In contrast, eight of the 19 patients with residu­
al stones were free of complaints — another indication of lack of relation between the 
presence of small stones and complaints. 
It can be seen in table 3, that patients with a blank history are most likely to be 
without complaints after ESWL. It can also be seen in table 3 that hematuria is clearly 
related to stone disease: in five of the six cases, hematuria disappeared with the stone. 
In 61% of the patients (11 out of 15) with persisting complaints after ESWL, another 
possible cause apart from stones could be determined speculatively retrospectively. 
Technical difficulties in treatment of small stones can be encountered. Using a 
Siemens Lithostar lithotripter with fluoroscopic guidance, we had difficulty in focus­
ing: the quality of fluoroscopic image on the antero-posterior monitor during treat­
ment was influenced by superpositioning of the waterbag, which resulted in time-
consuming positioning ( and long x-ray exposure). Improper focusing might have 
caused the low success rate in our series, although fragmentation was seen after 
ESWL in 32 patients (84%). The use of intravenous contrast medium or placement of 
a radiopacque stent might partly solve the problem, but we believe that this should be 
avoided in these patients if possible, to make treatment cost-effective. Intravenous 
contrast medium can also lead to complete visual loss of the stone, allergic reactions, 
and prolonged x-ray exposure, and epidural or general anaesthesia, needed for stent 
placement in males, can be associated with risks and results in prolonged hospitaliza­
tion. Only 50% of the stones were evacuated after ESWL, although fragmentation 
was seen in 32 patients (84%) immediately after ESWL. 
Absence of or decrease in pelvicalyceal motility as reported by Schulz et al. і 6 
might be responsible for the failure of fragmented stones to pass. 
In conclusion, we believe that one should be reluctant to treat small symptomatic 
renal calculi and await spontaneous evacuation, especially if the calculi are in the 
lower calyx. If no cause for abdominal or flank pain, hematuria, or upper urinary 
tract infection is discovered apart from the stone, ESWL can be performed. Only a 
relatively small group of patients, however, will become free of both stones and com­
plaints. 
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Abstract 
Calyceal diverticula calculi may cause complaints for which treatment is indicated. 
Both extracorporeal shock wave lithotripsy (ESWL) and percutaneous nephrolithola-
paxy (PNL) are recommended. 
We evaluated the results of ESWL treatment of stone-containing calyceal divertic­
ula and compared these with the results obtained by percutaneous surgery. 
In the ESWL-group (n=i5), patients were treated with an electromagnetic 
lithotripter (Siemens Lithostar). After three months, plain abdominal x-ray pictures 
revealed that only 2 patients (13%) were stonefree; these patients had no more com­
plaints. Of the 13 patients with residual fragments, 7 (54%) were free of complaints. 
The remaining 6 patients were treated by a lower pole resection (п=з), percutaneous 
treatment (n=2) and long term antibiotic treatment (n=i). 
Sixteen patient were treated percutaneously. Puncture failed in 3 and they were 
treated by lumbotomy. In the remaining 13 patients, stones were reached by direct 
puncture (n=i2) or via an adjacent calyx (n=i). After three months, 10 patients were 
stonefree and had no complaints. Morbidity consisted of post-operative bleeding 
(п=з) and high fever (n=i). We conclude that one should be reluctant in treatment of 
stone-containing calyceal diverticula. Only in symptomatic cases treatment is indica­
ted. ESWL is the first choice of treatment. If ESWL fails (residual stones and persis­
tent complaints), PNL should be performed although it is associated with a higher 
morbidity rate. 
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Introduction 
Extracorporeal shock wave lithotripsy (ESWL) has gained world wide acceptance as 
the treatment of choice for urinary tract calculi. Approximately 90% of all calculi can 
be treated effectively by this method (Chaussy, 1988). 
A pyelocalyceal diverticulum has a typical radiological appearance and is probably 
of congenital origin (Wulfsohn, 1980). 
Calyceal diverticula are found on routine intravenous urograms (IVU) in less than 
4.5 per 1000 IVU's (Midleton and Pfister, 1974; Timmons et al.,1975; Wulfsohn, 
1980). Although the symptoms may be similar to a hydrocalyx, it definitely is a differ-
ent condition: diverticula are found in the corticomedullary area (Wulfsohn, 1980). 
They may contain calculi and cause complaints such as hematuria, renal colic or uri-
nary tract infection for which treatment is indicated (Abeshouse and Abeshouse, 
1963). 
Psihramis and Dretler (1987), advocate ESWL being the best treatment for ca-
lyceal diverticula calculi. All calculi were fragmented but spontaneous evacuation oc-
curred in only 20% of the cases. 
ESWL is contra-indicated in case of an obstruction below the calculus which is 
the case in calyceal diverticula. The calyceal neck might hinder spontaneous passage 
of stone fragments (Wilbert et al.,1984; Thüroff and Alken,i985; Puppo, 1990). 
Therefore, other authors prefer percutaneous removal of these calculi, because the 
stone can be removed completely and the narrow calyceal neck can be dilated during 
the same procedure in order to prevent or delay stone recurrence (Hulbert et al., 1986; 
Thüroff and Alken, 1985). However, percutaneous surgery may have serious compli-
cations (Van Cangh et al, 1990). Because of this controversy, we retrospectively evalu-
ated the results of ESWL for calyceal diverticula calculi and compared these with the 
results obtained by percutaneous nephrolitholapaxy (PNL). 
Material and methods 
We reviewed the files of patients with stone-containing calyceal diverticula treated at 
our department with ESWL or PNL. Calyceal diverticula were defined according to 
Wulfsohn (1980): eventrations of the upper collecting system lying within the renal 
parenchyma and communicating with the main collecting system via a narrow chan-
nel (calyceal neck) (Figure 1.). 
Before treatment all patients underwent the following examinations: full history, 
physical examination, laboratory investigations, urine-culture and intravenous urog-
raphy (IVU). Thirty-one symptomatic patients were treated; 16 patients (6 males and 
10 females) by PNL between 1986 and 1988 and 15 patients (6 males and 9 females) by 
ESWL after January 1988, because at that time a lithotripter (Siemens Lithostar) was 
installed in our department. 
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All patients treated percutaneously had general anaesthesia. A 7 Fr. ureteral 
catheter was inserted and artificial hydronephrosis was created. Then the patient was 
turned in prone position and puncture of the stone-containing calyx was performed 
using both ultrasound and fluoroscopy. A guidewire was inserted and the percuta-
neous tract was dilated up to 30 Fr. The stone was removed by forceps and, if possible, 
the calyceal infundibulum was identified and dilatated up to 12 to 16 Fr. A multiholed 
balloon nephrostomy (12 Fr.) was left in place for a period of 3 to 6 weeks to allow the 
dilated infundibulum to heal. Patients were hospitalized for a minimum of 3 days. 
All 15 ESWL patients were treated on an outpatient basis. The technique of electro-
magnetic ESWL has been described previously by Wilbert et al. (1987). 
Patients were controlled 2 weeks, 1 month and 3 months after treatment. Of all 31 pa-
tients, 12 had a urinary tract infection and were treated with antibiotics for at least five 
days. In case of sterile urine (n=i9), patients had antibiotic profylaxis for one day. 
Figure 1: Kidney with bilateral calyceal diverticula 
Results 
The complaints of the patients at presentation are listed in table i. Hypertension or 
decrease in kidney function was never an indication for treatment. 
Table 1. Patients complaints 
number of patients 
ESWL PNL 
Pam 12 13 
Infection 4 8 
Hematuria 3 
Table 2. presents the stone localisation. The average stone size in the patients treated 
by ESWL was 94 mm2. 
Table 2. Stone localisation 
ESWL PNL 
Upper calyx 6 5 
Middle calyx 1 4 
Lower calyx 8 7 
In the first ESWL session an average of 3500 shocks was given (range 1200 to 4000 
shocks) at 18.1 kV. 
During treatment 7 patients (48%) needed analgesia (intravenous fentanyl citrate, 
max. dose 0.1 mg.). Within 3 months, 3 patients underwent a secondary ESWL ses-
sion because of persistent complaints. Besides transient hematuria and skin ecchymo-
sis in all patients, no complications were encountered (Table 3). The average treat-
ment time (including patients preparation and post-ESWL care) was 95 minutes 
(range 75 to 115 min.). X-ray exposure time ranged from 0.4 to 1.8 minutes (average 1.3 
min.). 
After 3 months plain abdominal x-ray pictures revealed that only 2 patients (13%) 
were free of stones. They were without complaints. The diverticula of 13 patients 
(87%) still contained stone fragments: in 7 patients stone size was reduced by ESWL 
and in 6 patients no effect of ESWL was seen. However, of these 13 patients, 7 (54%) 
had no more complaints. In the remaining 6 patients with persistent complaints a 
lower pole resection was performed in 3 and 2 had a successful percutaneous stone re-
moval with dilatation of the calyceal neck. The sixth patient was given long-term an-
tibiotic treatment because of persisting urinary tract infection. In table 3 the results of 
treatment are summarized. 
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Table 3. Results and complications of treatment. 
Complications 
•Hematuria 
•Ecchymosis 
•Access failed 
•P 0 -Bleeding 
Free of complaints 
Stonefree 
ESWL 
IS 
15 
9 (60%) 
2(13%) 
PNL 
3 
3 
10 (80%) 
10(80%) 
In the PNL group most patients complained of both pain and urinary tract infection. 
The causative micro-organisms were Proteus Mirabilis (n=5)) Escherichia Coli (n=2) 
and Staphylococcus Aureus (n=i). 
In 3 patients the calyceal diverticulum could not be punctured directly and they 
were treated by open surgery. In the 5 patients with calyceal diverticula in the upper 
pole, puncture was performed between the nth or 12th rib. In n patients one punc-
ture was effective and 2 needed a second puncture: in 1 patient the diverticulum could 
not be punctured directly and access to the renal collecting system was achieved by 
puncture of an adjacent calyx. In this patient the calyceal neck could not be identified 
and the stone was left in situ. 
In 10 patients the stones were extracted without problems by means of forceps. In 2 
patients small stone fragments were left behind. Of these 12 patients, the calyceal neck 
was identified in 9 and passed with a guide wire after which dilatation up to 12 to 16 
Fr. was performed. A nephrostomy (12 Fr.) tube was left in situ for 3 to 6 weeks. In 3 
out of 12 patients, the calyceal neck could not be identified; the wall of the diverticu-
lum was coagulated resulting in definite blockage of the connection to the renal col-
lecting system. This technique has been recommended by Wulfsohn (1980), especial-
ly if little or no surrounding renal parenchyma is present. 
Treatment time (excluded patients preparation and post-operative care) ranged 
from 60 to 120 min. with an average of 115 min. The average x-ray exposure time was 
5.5 min (range 3.6 to 7.2 min). 
Besides failure of puncture in 3 patients, resulting in open surgery, complications 
consisted of post-operative bleeding in 3 patients for which 2 patients needed packed 
cells. Despite optimal treatment the bleeding could not be stopped in 1 patient and 
selective embohsation of the bleeding artery was performed. Other complications 
consisted of post-operative fever ( >39.5 °C) in 1 patient which was treated successfully 
with antibiotics. Among the 5 patients who were punctured intercostally, the proce-
dure caused neither a pneumothorax nor a hydrothorax. No TUR syndrome oc-
curred in the treated patients. Hospitalization ranged from 3 to 21 days with an aver-
age of 6.7 days. 
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Of the 13 patients, 10 were stone-free and had no more complaints (80%) after a 
follow up of 3 to 36 months (mean 18 months). Three patients had residual stones and 
intermittent flank pain, treated with analgesics. Recurrent stone formation was seen 
in 3 patients after an average of 21 months. 
Discussion 
Calyceal diverticula calculi require treatment in case of chronic or recurrent pain, uri-
nary tract infection or in case of progressive renal damage (Hulbert et al.,1986; 
Timmons et al., 1975; Puppo, 1990). In certain cases, tuberculosis should be excluded 
before treatment is performed (Wulfsohn, 1980). 
Traditionally treatment has included surgical extraction of the calculus, closure of 
the communicating tract and obliteration of the diverticulum by marsupialisation 
and fulguration. Alternatively partial or total nephrectomy has been advised 
(Wulfsohn, 1980; Hulbert et al.,1987), but with the introduction of PNL and more re-
cently ESWL, these treatment modalities are obsolete (Thiiroff and Aiken, 1985; van 
Cangh et al.,1990). Symptomatic calyceal diverticula containing calculi are uncom-
mon and therefore it is hard to recruit large numbers of patients. 
Recently, reports on treatment of calyceal diverticula calculi with ESWL demon-
strated that the success rates (both stone- and symptom free) ranged from 20% to 
50% (Psihramis and Dretler, 1987; Ritchie et al., 1990; Wilbert et al, 1990, van Cangh 
et al., 1990). In our series, according to this definition, we found only a 13% success 
rate. Nevertheless, 70% of the patients can be without complaints after ESWL treat-
ment (Psihramis and DretlerjigSy). In our study, 54% of the patients with residual 
fragments were free of complaints, three months after ESWL treatment, whereas the 
overall percentage of patients without complaints was 60%. 
Because calyceal diverticula are lined by non-secretory transitional epithelium 
they contain urine that is derived by filling from the adjacent collecting system 
(Hulbert et al.,1986). Stasis of urine, especially in patients with a history of urolithia-
sis, will theoretically result in stone-recurrence and complaints. Especially in patients 
with urinary tract infections due to urease splitting bacteria, persistent complaints 
and stone-growth can occur if residual fragments are still present in the diverticulum. 
Although in the ESWL group 7 of 13 patients with residual stones were without com-
plaints after treatment, in 3 of 6 patients with residual stones a lower pole resection 
was performed because of persistent complaints. ESWL treatment is non invasive and 
can be performed on an outpatient basis with no or minimal anaesthesia, but its effec-
tiveness for calyceal diverticula calculi is doubtful. So far, no long-term follow-up 
studies have been reported with regard to recurrence of stone and complaints, but we 
believe that ESWL will often not lead to permanent success. 
The alternative for ESWL is percutaneous treatment (Hulbert et al., 1986; Puppo et 
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al.,1990 Thüroff and Alken, 1985). With this method of treatment, both the cause of 
stone formation and the stone itself can be treated and it should therefore be consid-
ered as a more definite treatment option (van Cangh et al., 1990; Puppo et al. ,199ο). 
Eighty per cent of our patients were stonefree and had no more complaints, 3 months 
after percutaneous treatment. 
The disadvantages of the percutaneous approach, as compared to ESWL, are the 
need for general anaesthesia, the hospitalization and the relative high complication 
rate (especially in puncturing above the nth rib). In a series of 22 patients treated by 
PNL, Van Cangh (1990) found major complications in three (14%), such as a-v fistula 
and hydrothorax. We encountered three severe post-operative bleedings (23%) and 
selective embolisation of the bleeding artery had to be performed in one patient. 
After PNL treatment, we found obliteration of the diverticulum in 3 patients 
(23%), and 3 patients (23%) had recurrent stone formation within an average of 21 
months. Several techniques have been described in order to reduce the complication 
rate and the stone recurrence. If overlying parenchyma is present the calyceal neck 
should be dilated and intubated for 1 to 3 weeks in order to minimize loss of kidney 
function and to decrease the complication rate (Thüroff and Aiken, 1985). If almost 
no overlying parenchyma is present the narrow calyceal neck should be closed by ful-
guration and complete extériorisation should be realized by resection of the roof 
(Wulfsohn, 1980) Hubert (1986) reported that 5 of 7 patients showed obliteration of 
the diverticulum on IVU 3 to 14 months after direct puncture and van Cangh et al. 
(1990) could not visualize the diverticulum post-opereratively in 80% of the patients. 
Therefore, fulguration of the diverticulum wall after stoneremoval could be a more 
effective way to reduce recurrent stone-formation. 
In conclusion we believe that ESWL should be the first method of treatment for 
calyceal diverticula calculi because of its non-invasiveness, although a high failure rate 
must be accepted and its long-term effect is unknown. 
Percutaneous treatment is more effective in rendering the patient stone-free and 
reducing complaints, but includes a higher complication rate. Therefore, PNL should 
be preserved for patients with persistent complaints after ESWL treatment. 
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Abstract 
In the application of extracorporeal shock wave lithotripsy for proximal ureteral and 
midureteral stones, both the in situ and the pushback or "push bang" treatments are 
recommended. In our center, 47 patients (38 males, 9 females) with uncomplicated 
ureteral stones were randomized to one of these methods and evaluated after 3 
months. The group having in situ treatment consisted of 23 patients and the group 
having the pushback treatment of 24 patients. All patients were treated with the 
Siemens Lithostar. In the in situ group, only seven patients needed intravenous anal-
gesia or sedation. The average number of shock waves delivered was 3100. After 3 
months, 21 patients (91 %) were free of stones. No major complications were noted. 
In the pushback group, 15 patients (all males) needed epidural and two intravenous 
analgesia or sedation. The pushback was successful in only 9 patients (37.5 %); the av-
erage number of shockwaves delivered was only 2000. Those nine patients were free 
of stones after 3 months. The pushback failed in 15 patients, and they were treated 
with the stones in situ. The average number of shock waves was 3100; 11 of the 15 
(73%) were free of stones after 3 months. In the pushback group, one serious compli-
cation occurred: one patient suffered a severe headache after epidural anaesthesia. 
Epidural anaesthesia is mandatory for all men in this group. We conclude that, in 
spite of the higher number of shocks, in situ treatment of proximal and midureteral 
calculi is preferable to pushback, especially in men. 
Introduction 
Since the first successful extracorporeal shock wave lithotripsy (ESWL) was reported', 
the technique has become routine in the treatment of renal and ureteral calculi. With 
increasing clinical experience, it had been found that ureteral calculi do not respond 
as well as do renal calculi. 
Results of several in vitro studies of the effects of shock waves on ureteral calculi 
have implicated impaction as a cause of the poor success of in situ ESWL treatment of 
ureteral calculi2. 
Graf and associates3 therefore postulated that the success rate of ESWL of proxi-
mal and midureteral calculi could be increased if the calculi were pushed up into the 
renal collecting system. 
However, other reports have shown good results of in situ treatment of ureteral 
calculi4. 
Since January 1988, a Siemens Lithostar lithotripter has been installed in our depart-
ment. After the first 500 patients, we evaluated the results in 37 patients with proxi-
mal ureteral and midureteral calculi. One group (12 patients) had in situ treatment; 
the other (25 patients) had the "push-bang" or pushback treatment (Table 1). 
Table 1. Treatment results in non-randomized series of upper ureteral calculi. 
number stonefree 
In situ treatment 12 11(91%) 
Treatment with auxiliary procedures (pushback) 25 22 (88 %) 
Although the group of patients was small and treatment results could have been bi-
ased by selection, the results seemed to indicate that ureteral calculi located above the 
sacroiliac joint could best be treated in situ. 
To resolve the controversy concerning this subject we started a randomized trial 
for ESWL of proximal ureteral and midureteral calculi. 
Patients and methods 
The prospective trial was conducted between June and November 1988 and included 
57 patients with proximal ureteral and midureteral calculi. We excluded patients 
treated formerly with ESWL for a ureteral stone, patients whose stones were poorly 
visible on plain films, and patients with a nephrostomy or other catheter at the site of 
treatment (Table 2). 
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Table 2. Definition of study group. 
Randomized: n=57 stone passed spontaneously 3 
stone m the lower ureter 3 
ESWL session stopped) technical problem ) 1 
additional treatment 3 
Evaluable after three months 47 
Excluded: n=16 nephrostomy catheter 9 
ureteral catheter in situ 2 
poorly visible stones 2 
former ESWL treatment 2 
solitary kidney 1 
We categorized calculi by the anatomic segment of the ureter at the time of the first 
visit at our outpatient department according to a recent intravenous urogram (IVU). 
Proximal ureteral calculi were in the upper one-third of the ureter, and midureteral 
calculi were in the middle one-third of the ureter. 
Stones were treated according to randomization. We randomized for in situ or 
pushback treatment. If the stone had left the upper two-third of the ureter, the pa-
tient was excluded from the study (table 2). 
One patient could not be treated properly because of a technical problem with the 
machine, and three others, two randomized for in situ and one for pushback, needed 
additional treatment (nephrostomy catheter) before the final evaluation date, because 
of serious colic or pyelonephritis (Table 2). The stone of three patients passed sponta-
neously. Finally, a group of 47 patients was left for evaluation. The ages of the 38 men 
and 9 women ranged from 13 to 72 years (mean 48 years). We randomized 23 patients 
(19 males, 4 females) for in situ treatment. The pushback group consisted of 15 males 
and 9 females. Auxiliary procedures were performed with fluoroscopic guidance. 
The pushback technique consisted primarily of pushing with a 6F or 7F ureteral 
catheter and, if that was not successful, by flushing through the catheter. If both tech-
niques failed to replace the stone in the renal pelvis, it was treated in situ. Stone size 
was measured from anteroposterior plain X-ray films taken just before treatment. 
Complications caused by ESWL, anaesthesia and auxiliary procedures were regis-
tered. 
All patients were treated with the Siemens Lithostar lithotripter. Shocks were gen-
erated by electromagnetic discharge of 13.1 kV. after an initial dose of 200 shocks with 
rapidly increasing voltage to 18.1 kV. The number of shocks delivered during each 
treatment ranged from 1000 to 4000. During treatment, disintegration was moni-
tored fluoroscopically. Each patient was treated in one session. 
All patients had antibiotic prophylaxis: Cotrimoxazole 960 mg twice a day for 2 
days. Patients with a urinary tract infection were treated with antibiotics for at least 5 
days according to the results of the urine culture. 
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Data were recorded during follow-up ι day, 2 weeks and 3 months after ESWL. All 
data were analyzed according to chi-square testing to assess significance. 
Results 
As shown in Table 3, in the in situ group, 15 stones were in the proximal part and 8 in 
the midureter. The average stone surface area was 59 m m 2 . All patients were treated 
in the supine position. The number of shock waves delivered per treatment ranged 
from 1000 to 4000 (average 3100) at 18.1 kV. (Figure 1 and 2). 
In 16 patients (70%) no anaesthesia during treatment was necessary. Three pa­
tients needed intravenous analgesia (0.1 mg of fentanyl), one needed intravenous se­
dation (io mg of diazepam), and three needed both. 
In eight cases, treatment was an outpatient procedure. These patients had no di­
latation at the site of treatment after ESWL. Ten patients were admitted to the refer­
ral hospital after treatment for 1 day, and five patients were treated during admission 
in our own hospital (2 days of hospitalization because of renal colic). The mean dura­
tion of hospitalization was less than 1 day. 
After treatment, 12 patients (52%) suffered from colical pain. Five of them needed 
oral analgesia. One patient had fever 38.5 0 C. No major complications were observed. 
After 3 months, 21 patients (91 %) were free of stones according to plain films. The 
two patients who were not stone free at this time had presented with moderate and se­
vere dilatation at our outpatient department. They were treated invasively. The stone 
composition in both cases was calcium oxalate monohydrate. 
In the 24 patients randomized for pushback treatment, 18 stones were in the proxi­
mal ureter and six in the midureter. The average stonesize was 50 m m 1 . Retrograde 
manipulation was successful in only 9 patients. Hence, 15 patients were treated with 
the stones in situ. 
In the group in which the pushback was successful, six stones were in the proximal 
ureter and three in the midureter. 
The average stonesize was 58 m m 1 . During the auxiliary procedure and treatment, 
four female patients needed no anaesthesia, one woman needed intravenous analge­
sia, and four men needed epidural anaesthesia. The average number of shock waves 
given for the stones that were manipulated into the renal collecting system was 2000. 
Hospitalization lasted an average of 1.2 days. After treatment, four patients suffered 
from colic pain, which was treated with analgesics. One patient had prolonged 
macroscopic hematuria (3 days). 
After 3 months, all patients were free of stones according to plain films. 
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Figure ι: In situ ESWL for a midureteral calculus 
In the 15 patients whose stones could not be pushed back, 12 stones were in the proxi­
mal ureter and three in the midureter. The average stone size was 50 mm". Auxiliary 
procedures and treatment required epidural anaesthesia in 11 men, intravenous anal­
gesia in one woman, and no anaesthesia in four women. The average number of 
shock waves given for the stones that could not be pushed back was 3100. The mean 
duration of hospitalization was 1.3 days. No complications attributable to endoscopic 
manipulations were noted, but five patients suffered from colic pain, which was treat­
ed with analgesics, and one patient had a severe headache, probably caused by the 
epidural anaesthesia. 
After 3 months, и of the 15 patients were free of stones. Of the four patients who 
were not stone free, one had presented with severe dilatation at our outpatient depart­
ment and three with moderate dilatation at the site of treatment. Table 3 presents the 
results in the three groups. 
5S 
Figure 2: Fragmentation after 4000 shocks at 18.ι kV. 
In Table 4 the presence of dilatation at the treated site in the three groups is presen­
ted. 
Although the series is relatively small, it can be seen that in the group in which the 
pushback failed, more patients presented with moderate and severe dilatation, proba­
bly correlating with impaction, compared with the group in which the pushback was 
successful. 
The composition of all stones could not be traced, but in the four patients of the 
failed pushback group who were not stonefree after 3 months, one patient proved to 
have a calcium oxalate monohydrate stone. Two others had a partial disintegration of 
their stones (the stones had changed configuration according to plain films), and a 
second ESWL was successful. Stone composition in both patients was mainly calcium 
oxalate dihydrate. In the fourth patient, stone analysis could not be performed. Table 
5 presents the stone composition in the patients who were not stonefree. 
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Table 3. Results of treatment according to protocol 
Average stone size 
Location 
proximal ureter 
midureter 
Intravenous analgesia 
Intravenous sedation 
Both IV sedation and analgesia 
Epidural anaesthesia 
No of shock waves 
Duration of hospitalization (days) 
No stonefree ( % ) after three months 
In situ 
(n=23) 
59 mm2 
15 
8 
3 
1 
3 
0 
3100 
0 85 
21(91) 
Pushback successful 
(n=9) 
58 mm2 
6 
3 
1 
0 
0 
4 
2000 
12 
9(100) 
Pushback unsuccessful 
(n=15) 
50 mm2 
12 
3 
1 
0 
0 
11 
3100 
13 
11(73) 
Table 4 Number of patients (%) with various degrees of dilatation in the three groups according to recent 
intravenous urogram 
In situ 
n=23 
No dilatation 
Slight dilatation 
Moderate dilatation 
Severe dilatation 
8(35) 
10(43) 
4(17) 
1(4) 
Pushback successful 
n=9 
3(33) 
4(45) 
2(22) 
Pushback unsuccessful 
n=15 
4(27) 
3(20) 
6(40) 
2(13) 
Table 5 Relation between failed ESWL and stone composition 
In situ 
(n=2) 
Ca oxalate monohydrate 
Ca oxalate di hydrate and ca oxalate monohydrate 
Unknown 
Successful pushback 
(n=0) 
Failed pushback 
(n=4) 
Discussion 
There is controversy over in situ versus push-bang techniques for ESWL of ureteral 
calculi ^5. 
Stones smaller than 5 mm (25 mm2 ) can evacuate spontaneously and should not 
be treated, especially if they are already in the lower ureter. Moreover, 80 % of all cal-
culi that reach the ureter will pass spontaneously6. 
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Stones in the upper two-third of the ureter that are larger than 5 mm should be 
treated if colicky pain prevents the patient from working, if infection is present, or if 
the renal function is deteriorating. If a lithotripter is available, three main possibilities 
are suggested: treatment of the ureteral calculus in situ, ESWL treatment of the stone 
after pushing it up into the renal pelvis, and ESWL with a stent beside the stone 7. 
The disadvantage of in situ treatment is the higher number of shock waves needed for 
disintegration because of impaction of the stone. 
The disadvantage of the push-bang technique or placement of a stent beside the 
stone (in second-generation lithotripsy) is the anaesthesia needed, especially in male 
patients, for the ureterocystoscopy and the ureteral stone manipulation. The push-
back technique has a higher complication rate: ureteral perforation 8 and complica-
tions secondary to the epidural anaesthesia such as hypotension. 
In our population, the number of shock waves needed for stone disintegration was 
significantly lower (p = 0.0250) in the pushback than in the in situ cases. That has 
also been reported by other investigators 9. Comparison of the success rate of ran-
domized treatment after (failed) manipulated ureteral calculi with that of stones treat-
ed primarily in situ cannot be fully justified. A stone that can be moved into the renal 
collecting system is probably not firmly impacted and therefore is easier to fragment 
than a truly impacted stone that cannot be manipulated back into the renal pelvis 7. 
Our results confirm that: the success rate of the stones treated in situ after unsuccess-
ful pushback was lower than the rate of the those treated primarily in situ (73 % and 
91 %). 
Because in the failed pushback group, relatively more patients had moderate and 
severe hydronephrosis at the site of treatment, presumably indicating impaction, the 
success rate was lower in this group than in those treated primarily in situ despite the 
smaller stonesize. Another explanation might be that in the failed pushback group, 
more patients had hard stones (monohydrate). We did not mention the stone compo-
sition in the three groups because only 60% of the patients presented their fragments 
for analysis, but we carefully traced the cases of failed disintegration and found a high 
percentage of calcium oxalate monohydrate stones (Table 5). Unfortunately, it is not 
possible to predict stone composition in a patient before ESWL treatment and select 
the patient on that basis for specific treatment. 
We did not correlate the duration of symptoms with successful fragmentation, as 
other investigators did5. We believe that figure to be unreliable, inasmuch as a patient 
can have complaints before the stone is found in the ureter, and ureteral stones may 
not produce symptoms for some period. In our patient population, ureteral stones 
were always treated on semiurgent base within 2 weeks after diagnosis, irrespective the 
complaints of the patient. 
We excluded patients whose ureteral stones were accompanied by special circum-
stances (such as placement of a nephrostomy catheter). Patients with stones poorly 
visible on radiographs were excluded because successful pushback might lead to visual 
loss of a stone in the renal collecting system. 
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We found no relation between stone size and the success of pushback (p= 0.191) al-
though others have found such a correlation I0. Nor did we find a correlation between 
stone location and the success of pushback. Relatively more proximal stones failed to 
be pushed back. The presence of hydronephrosis at the site of treatment might be an 
indication for successful retrograde manipulation: in the 24 patients randomized for 
this method, the pushback succeeded in neither of the two patients with severe dilata-
tion, whereas there was a 25% success in the patients with moderate dilatation, and in 
almost half of the patients with slight dilatation at the site of treatment, the pushback 
was successful. The best explanation is that impaction is the main cause of both fur-
ther descent and unsuccessful retrograde manipulation. 
Extracorporeal treatment with a Lithostar lithotripter is not as painful as that with the 
first-generation machines ". In the group of patients whose stones were treated in 
situ, only a few required intravenous sedation or analgesia. In the pushback group, 
epidural anaesthesia was given to all men, because we did not want our results influ-
enced by pain reactions, as had been experienced in a pilot study in which male pa-
tients received no epidural anaesthesia. The relatively small number of successful 
pushbacks is probably secondary to reluctance to use force in moving stones to the in-
tended location, which could have complicated the manipulation by perforating the 
ureter and creating extravasation. 
All men in whom retrograde manipulation failed had epidural anaesthesia. We be-
lieve that they were placed unnecessarily at risk for complications by this form of 
anaesthesia, because the success rate of pushback was only 38%. 
We therefore recommend that all male patients with stones in the upper two-thirds of 
the ureter be treated with ESWL in situ without auxiliary procedures. In female pa-
tients, one can try to push a stone into the renal pelvis if no anaesthesia is needed, be-
cause the results of ESWL after successful retrograde manipulation are slightly better 
than the results of ESWL in situ for stones in the ureter. If stone configuration does 
not change after ESWL, especially in cases with severe dilatation, other, more inva-
sive, treatment modalities should be considered. 
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Abstract 
The treatment of choice for stones in the lower third of the ureter is still to be demon-
strated. Extracorporeal shock wave lithotripsy (ESWL) in situ (IS) and with a loop 
catheter (LC) around the stone are both recommended. We randomized 44 patients 
with such stones into those two treatment groups. Each group consisted of 22 pa-
tients. After 2 weeks, 8 (36%), and after 3 months, patients (41%), were stone free in 
the IS group. Impaction resulting in hydronephrosis at the site of treatment was asso-
ciated with a low likelihood of success in this group. In the LC group, all 16 men 
needed epidural anaesthesia during treatment. The LC positioning failed in 9 of the 
22 patients. Five of the nine (56%) were stone free after 2 weeks. In the other 13 pa-
tients, the LC was successfully positioned, and 6 (69%) were stone free after 2 weeks. 
The rate of absence of stones was almost twice as high after LC treatment as after IS 
treatment. Although epidural anaesthesia was mandatory in men and LC positioning 
did not succeed in 41% of the cases, we believe that LC use is justified, especially in 
cases of impaction proved by hydronephrosis. If dilatation is absent, ESWL in situ 
can be performed. If disintegration or evacuation fails and hydronephrosis persists 2 
weeks after treatment, ureterorenoscopy can be performed. 
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Introduction 
Since the introduction of extracorporeal shock wave lithotripsy (ESWL), treatment 
for stones in the urinary tract has changed dramatically 1·2. Treatment of ureteral 
stones with ESWL is still controversial. For stones in the upper two-thirds of the 
ureter, both in situ and "push-bang" methods are recommended 3'4, but stones in the 
lower one-third of the ureter constitute a challenge for ESWL treatment. The use of a 
loop catheter (LC) around a stone seems to increase the success rate of ESWL of 
lower ureteral stones 5. Good results were reported for in situ (IS) treatment with the 
Dornier HM3 lithotripter and a modified technique 6, but general or epidural anaes-
thesia was necessary. 
In January 1988, a Siemens Lithostar lithotripter was installed in our department. 
It has been used in more than 1,600 treatments, 87% without epidural or general 
anaesthesia. The first results of IS treatment of lower ureteral stones were not very en-
couraging: absence of stones after 3 months in 25% of the cases. To quantify the dif-
ference in success between ESWL IS and the combination of ESWL and a LC around 
the stone, we started a prospective randomized trial. 
Material and methods 
Since July 1988, patients with previously untreated stones in the lower one-third of 
the ureter have been randomized at their first visit to our outpatient department for 
ESWL treatment IS or ESWL with an LC. Patients with a nephrostomy catheter were 
excluded from the study. A total of 44 patients (33 men and 11 women) were included 
in the study. Their average age was 51.6 years (range 22-82 years). 
Intravenous urography (IVU) and ultrasonography (US) of the kidneys were per-
formed before the patients were taken into the study. On the day of treatment, a plain 
film was made, and stone surface area was measured. 
For patients randomized to the LC group, we used an Angiomed 6F LC. Under 
fluoroscopic control, the catheter was passed alongside the stone, and the loop was 
opened in the renal pelvis with the patient supine. Then the opened loop was lowered 
in the distal ureter until it surrounded the stone (Figure 1), and the patient was placed 
in the prone position for optimal focusing. To prevent uncontrolled movements be-
cause of pain, as was experienced in a pilot study, all men randomized for LC treat-
ment had epidural anaesthesia. If the catheter could not pass the stone, IS treatment 
was used. Each patient was treated in one session. 
The number of shocks administered ranged from 800 to 4000. The voltage used 
was 18.1 kV. During treatment, fragmentation was monitored with fluoroscopy. If 
fragmentation was seen, or after 4000 shocks, a new plain film was taken to judge 
fragmentation accurately. After treatment, US of the kidney was performed in order 
to document the presence of or change in hydronephrosis. 
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All patients had antibiotic prophylaxis with Cotrimoxazole (960 mg twice a day for 2 
days). Patients with a urinary tract infection were treated with antibiotics for at least 5 
days, according to the antibiogram. 
Figure 1: An Angiomed loop catheter surrounding a ureteral stone 
Results were evaluated after 2 weeks and 3 months. Treatment was considered success-
ful if the ureter was seen to be stone free on a plain film after 2 weeks. If stones or 
residual fragments were present after 2 weeks and the clinical situation demanded in-
tervention (for persistent hydronephrosis), the initial treatment was regarded as un-
successful, and the patient was treated again. If no dilatation was present 2 weeks after 
treatment and the patient had no complaints he was treated conservatively, as the kid-
ney was not at risk. 
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Results 
Treatment in situ 
We treated 22 patients with ESWL IS. The average stone size in this group was 55 
mm
2
. Before treatment, moderate to severe hydronephrosis was seen on US or IVU in 
15 patients. The average stone size in the hydronephrotic patients was 64 mm2 , 
whereas it was 34 mm2 in the seven patients with no dilatation. During treatment, 14 
patients needed analgesia ( a maximum of 2 ml fentanyl: 0.05 mg/ml). The average 
number of shock waves administered was 3747. 
After 2 weeks, eight of the 22 patients (36%) were free of stones. The likelihood of 
success was correlated with absence of hydronephrosis at the time of treatment: only 
two of the 15 patients with hydronephrosis were stonefree (13%), whereas six of the 
seven patients (86%) without hydronephrosis at the time of treatment were stonefree 
after 2 weeks according to plain films. 
Of the 14 patients with residual stones after two weeks, 10 had persistent hy­
dronephrosis and underwent a second treatment (six ureterorenoscopy and four 
ESWL). In three patients, the amount of stone in the lower ureter was reduced, the 
hydronephrosis resolved, and spontaneous evacuation could be expected; one of the 
three passed the fragments within 3 months. One patient without hydronephrosis at 
the time of treatment also was treated conservatively. 
Treatment with LC 
We treated 22 patients with ESWL and LC. The average stone size in this group was 
50 mm2 . All 16 men had epidural anaesthesia, and six females needed intravenous 
analgesia because of pain during the introduction of the catheter or pain caused by 
ESWL. 
Positioning of the LC failed in nine patients, and they were treated with ESWL IS. 
Stone size in those nine patients was significantly smaller than in the 13 in whom the 
loop was positioned successfully (31 mm2 vs. 59 mm 2 ; ρ < 0.05). In only three of the 
nine patients was dilatation present before treatment. 
The average number of shock waves administered to the nine was 3,485. Within 2 
weeks, five (56%) were stonefree. Of the four patients with residual fragments who 
were treated conservatively, three passed their stones spontaneously within 3 months. 
In 13 patients, the LC was positioned successfully (Figure 2). The average number 
of shock waves delivered was 2,880. The two patients without hydronephrosis were 
stonefree after 2 weeks, as were 7 of the 11 patients with hydronephrosis. That is, of 
the 13 (96%) were stonefree. Of the four patients with residual fragments, one had a 
second ESWL treatment, and three were treated conservatively, because they were 
without complaints and no dilatation was seen with US during follow-up. One of 
them evacuated the stones within 3 months. 
Overall results are summarized in Table 1. 
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Table 1 Overall results of treatment 
In situ 
No of patients 
stone size,mm2 
Average no Shockwaves 
No (%) stonefree 
2 weeks 
3 months 
22 
55 
3747 
8(36) 
9(41) 
9 
31 
3485 
5(56) 
8(89) 
13 
59 
2880 
9(69) 
10(77) 
Table 2 shows the relation between dilatation and stone size, and Table 3 shows the re-
lation between dilatation and success at 2 weeks. 
In both groups, most patients experienced discomfort in the back, which was at-
tributable to the prone position. There were no serious complications in the IS group. 
One patient in the LC group suffered severe headache secondary to epidural anaes-
thesia. All patients were hospitalized after treatment for a maximum of 24 hours. 
Table 2. Correlation between stone size and presence of dilatation 
Stone size (mm2 surface area) No patients with dilatation 
10 19 
20-29 
30-39 
40 49 
50-59 
60 69 
70-79 
80 89 
90 99 
>100 
No patients without dilatation 
Table 3 Results of treatment in three groups in relation to presence of dilatation 
Dilatation at treatment site 
In situ n=15 
Failed loop n=3 
Successful loop n=11 
No dilatation at treatment site 
In situ n=7 
Failed loop n=6 
Successful loop n=2 
No (%) stonefree after 2 weeks * 
2(13) 
2(67) 
7(64) 
6(86) 
3(501 
2(100) 
No (%) stonefree after3 months * 
3(20) 
2(67) 
8(73) 
6(86) 
6(100) 
2(100) 
* only conservatively treated patients 
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Figure 2: Successful loop positioning Fragmentation after 4000 shocks at 18.1 kV 
Discussion. 
Only a few randomized trials on ESWL treatment of lower ureteral stones have been 
reported. The low success rates, the high retreatment rate of ESWL IS, and the type 
of anaesthesia used for positioning the LC have stimulated the application of 
ureterorenoscopy for treatment of lower ureteral stones. 
The success rate of ureterorenoscopic removal of lower ureteral stones ranges from 
69% to 99% 7·8, but ureterorenoscopy can cause damage to the ureter such as stric-
tures due to mucosal disruption, bleeding, ureteral perforation, ureteral avulsion and 
stenosis9"". Schultz et al reported a 25% failure rate with rigid ureteroscopy I2, and 
Kramolowsky reported a 15% incidence of ureteral perforation in 142 ureteroscopic 
procedures '3. The use of flexible instruments might reduce the incidence of compli-
cations, but the method is not yet widely applied and is less effective, because the 
working channel is relatively small '. Therefore, ESWL is the treatment of choice for 
lower ureteral stones. 
With a first-generation lithotripter, difficulties in identification of the stones 
using X-ray and application of shock waves were encountered6. According to Tiselius 
et al, ESWL with a Dornier HM3 lithotripter can be used for stones in the ureter up 
to 2 cm above the sacroiliac joint '4. Recently, Ackaert and associates reported new po-
sitioning techniques to facilitate the use of the HM3 lithotripter for lower ureteral 
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stones I5. We had no difficulty in positioning patients with the Lithostar lithotripter. 
Patients can be treated in the prone or supine position. Focusing is through the pelvic 
window in the prone position. In the supine position, prevesical stones can be fo-
cused through the foramen obturator with the patient "sitting" on the shock head. 
Furthermore, the need for epidural or general anaesthesia was reduced. The only pa-
tients requiring epidural anaesthesia were men whom required auxiliary procedures. 
Intravenous analgesia could be used in the other patients. 
High success rates were reported for IS treatment of lower ureteral calculiö''', but 
in our series, the rate was only 36% after 2 weeks. The main explanation of the differ-
ence is that our patients had only one single treatment to prevent bias. 
Stone disintegration depends on particle expansion, which is slight or nonexistent 
in the lower ureter. In our series, that was clearly demonstrated; the success rate for IS 
treatment of lower ureteral stones seemed to depend on the presence of dilatation (as 
a result of stone impaction) at the site of treatment (see Table 3). Larger stones caused 
more obstruction; obstructing stones were much larger than the nonobstructing 
stones. The average number of shocks given to the patients with impacted stones was 
3800, compared with 3640 shocks given to patients with nonimpacted stones. Other 
authors have suggested that a greater number of shock waves and higher discharge 
voltage might compensate for the lack of expansion space in the lower ureter "\ To 
overcome the problem of impaction, pushing the ureteral stone up into the renal 
pelvis has been suggested 4''7. That might be the preferred treatment for midureteral 
and upper ureteral stones, but according to Evans et al, lower ureteral stones could be 
pushed up in only 30% of the patients4. 
Recently, an LC surrounding the stone was used to create a wet capillary slit, in-
creasing the wet surface area around the stone s. That should improve the disintegra-
tion. The LC also facilitates focusing, because it improves visibility of the stone. 
According to Selli and Carini, the LC could not be positioned in 40% of patients, but 
stones could be eliminated in 94.2% of patients if the loop surrounded the stones5. In 
our series, we could not position the loop in 41% of patients (9 out of 22). In the 
group in which placement failed, stones were significantly smaller than in the group 
in which it succeeded. Failure of loop positioning was secondary to difficulty in mo-
ving the LC past the stone (one case) or crossing the vascular bridge (three cases). In 
five cases, the loop surrounded the stone but slipped off when the patient was turned 
from supine to prone, possibly because the stones were small. Small stone size, obvi-
ously correlated with dilatation in only 33% of the cases, probably caused the high 
success rate in the nine patients treated IS as a second choice (see Table 3). 
For patients with lower ureteral stones and dilatation, the use of an LC seems to be 
the preferred method of treatment: the success rate in 2 weeks was 64%, compared 
with 13% in the IS group ( ρ < 0.05) (Table 3). LC positioning was successful in 79% 
of the cases (11 out of 14). We noted with interest that 22 of the 27 patients who even­
tually became stonefree (81%), were stonefree 2 weeks after treatment. 
Because of the high frequency of dilatation in the total group (29/44; 66%) and 
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the well-known risks of kidney damage and infection, the result of treatment should 
be judged within 2 weeks. If dilatation persists or increases, a second treatment should 
be planned, instead of delaying to evaluate the treatment after 3 months. 
In conclusion, we recommend that lower ureteral stones be treated IS if no hy-
dronephrosis is present, because the use of an LC does not improve the success rate of 
ESWL. The application of an LC might be considered in patients with dilatation. 
The results of treatment should be evaluated within 2 weeks. If stones do not respond 
to ESWL and hydronephrosis is persistent, a ureteroscopic approach is justified. 
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Abstract 
Extracorporeal shock wave lithotripsy can be painful. Of our population of patients 
treated with a Siemens Lithostar device, 51.4 % needed intravenous analgesia. A eu-
tectic mixture of local anaesthetics, a hydrophillic cream containing 25 mg. lidocaine 
and 25 mg. prilocaine per gm., proved to be effective for local analgesia. Therefore we 
investigated its effectiveness during extracorporeal shock wave lithotripsy. With ran-
domized, double-blind, application the eutectic mixture of local anaesthetics and 
placebo were evaluated in 83 patients according to the percentage of patients who re-
quired intravenous analgesia during extracorporeal shock wave lithotripsy. 
Of 40 patients treated with the eutectic mixture of local anaesthetics 12 (30%) 
needed supplementary fentanyl citrate. Of 43 placebo-treated patients, 23 (53%) 
needed fentanyl citrate. The EMLA treated patients probably experienced less pain at 
the cutaneous level. Although there is no statistical significance (p = 0.32), the eutec-
tic mixture of local anaesthetics does decrease pain during extracorporeal shock wave 
lithotripsy and it should be particularly useful for patients in whom intravenous anal-
gesia is contraindicated. 
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Introduction 
The eutectic mixture of local anaesthetics (EMLA), a hydrophillic cream containing 
25 mg. lidocaine and 25 mg. prilocaine per gm., is useful for topical anaesthesia. Its ef­
fectiveness has been proved in adults ' and children г for painless venous blood sam­
pling. The removal of condylomata acuminata has been successful with the patient 
under local anaesthesia with EMLA 3, and its efFectiveness for painless outpatient 
treatment of the preputial accretion has been described4. 
Extracorporeal shock wave lithotripsy (ESWL) can be painful. In the treatment of 
uncomplicated urinary tract calculi with a Siemens Lithostar lithotripter, 51.4% of 
our patients needed intravenous analgesia (fentanyl citrate, maximal dose 0.1 mg.). It 
could be expected that the deep, local penetration of the skin by EMLA would de­
crease the pain and make it possible to decrease or even omit the dose of fentanyl cit­
rate. 
We began a prospective double-blind randomized trial to determine the therapeu­
tic efficacy of EMLA in ESWL for urinary calculi. 
Material and methods 
We included in our study patients who had not been treated previously with the 
Siemens Lithostar device at our institution from September through November 1989. 
We excluded patients who needed epidural, spinal or general anaesthesia (men in 
whom auxiliary procedures had to be performed and children) and those in whom 
fentanyl citrate was contraindicated. 
Application of EMLA cream and placebo cream was randomized and double-
blind; half the patients received each agent. All patients were told that they received 
an anaesthetic cream. We applied 30 gm. of cream 1 hour before treatment on the skin 
(100 cm2 ) at the site of shock-head coupling. The site of coupling was determined by 
examining a recent plain x-ray (less than 2 weeks old). The cream was covered with 
transparent dressing which was removed before coupling of the shock head so that it 
could not influence the power of the shocks5. 
Patients with a ureteral stone overlying a transverse process or with a lower ureteral 
stone were treated in the prone position and other patients were treated in the supine 
position. The number of shocks per treatment varied from 1,000 to 4,000. The 
shocks began at 13.9 kV. and increased to 16.9 kV. after 1,000 shocks. After 1,500 
shocks 17.5 kV. was used. 
Side effects, if any, were registered. After each 500 shocks pain was recorded ac­
cording to a visual-analogue scale. Fentanyl citrate (0.05 mg intravenously) was given 
on patient demand. All patients were treated by 1 investigator to avoid bias. EMLA 
cream was regarded as effective if the proportion of patients needing fentanyl citrate 
could be decreased by 50%. Our control population consisted of 798 patients treated 
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in 1988 (table 1). Statistical significance (p < 0.05) was tested according to chi-square 
analysis. 
Table 1. Use of anaesthesia in pre-study control population. 
Ureteral stones Renal stones Totals 
No. patients 193 605 798 
No. % patients with no anaesthesia 102 (52.8) 286 (47.3) 388 (48.6) 
No. % patients with fentanyl citrate 91(47.2) 31(52.7) 410(51.4) 
Results 
Cream was applied to 92 patients. Of the patients could not be evaluated: in 4 stones 
had already passed, in 4 the stones changed position within 2 weeks before the cream 
was applied and treatment of 1 was stopped because of malignant hypertension. Of 
the remaining 83 patients 40 received EMLA and 43 received the placebo cream. 
EMLA 
We studied 27 men and 13 women with a mean age of 50.6 years (range 26 to 84 
years). Patients were treated while in the prone (n=i8) or the supine (n=22) position. 
During treatment, 12 patients (30%) needed intravenous fentanyl citrate. The average 
pain score at intravenous drug administration was 6.9. Fentanyl citrate was given 
early in the treatment (during the first 500 shocks) in 7 patients and during the sec­
ond 500 shocks in 2. One patient needed fentanyl citrate after 3,000 shocks. Two pa­
tients needed two doses of fentanyl citrate: 1 during the first 500 shocks and after 
1,500 shocks, and 1 after 2,000 and after 3,000 shocks. The average dose of fentanyl 
citrate in the 12 patients (average weight 73.2 kg.) was 0.79 JJg./kg. 
PUcebo 
We studied 32 men and π women with a mean age 48.5 years (range 28 to 73 years). 
Patients were treated while in the prone (n=22) or the supine (n=2i) position. During 
treatment 23 patients (53%) needed intravenous fentanyl citrate. The average pain 
score was 7.2. 
In 13 patients 1 dose of fentanyl citrate was sufficient while 10 received 2 doses. 
Because of severe pain, treatment had to be stopped at an early stage in 1 patient. The 
first dose of fentanyl citrate was given during the first 500 shocks in patients, between 
500 and 1,000 shocks in 3, between 1,000 and 2,000 shocks in 5, and after 2,000 
shocks in 6. A second dose was given after 1,000 shocks in 3 patients, after 1,500 
shocks in 1, and after 2,000 shocks in 6. The average dose of fentanyl citrate in the 23 
patients (average weight 72.8 kg.) was 0.98 (Jg./kg. We noted no side effects of the 
EMLA and placebo creams. There were no differences in magnitude of pain between 
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patients with ureteral stones (treated mainly while in the prone position) and kidney 
stones (supine position), (table 2.) 
Table 2 Stone location and necessity for intravenous fentanyl citrate. 
Stone location 
Calyx 
Pelvis 
Ureter 
Totals 
Pain scores 
EMLA 
18 
7 
15 
40 
No patients 
Placebo 
19 
3 
21 
43 
No (%) patients need 
EMLA 
6(33) 
2(29) 
4(27) 
12(30) 
ng fentanyl citrate 
Placebo 
10(58) 
1(33) 
12(52) 
23 (53) 
Figure 1 shows the average pain score of all patients in both groups. Figure 2 shows the 
average pain score of patients in both groups who did not need fentanyl citrate. 
2 5 av painscore 
500 1000 1500 2000 2500 3000 3500 4000 
no shocb • EMIA • Placebo 
500 1000 1500 2000 2500 3000 3500 4000 
no shocks • EM IA • Placebo 
Figure 1: Average painscore of all patients 
in both groups 
Figure 2· Average painscore of patients who did not 
need fentanyl-citrate 
Discussion 
ESWL with a first-generation lithotripter is performed with the patient under gener-
al, epidural, or spinal anaesthesia to relieve pain 6'7. Some patients could be treated 
with local anaesthesia8, or with intravenous sedation and analgesialo. With the intro-
duction of second-generation lithotripters the use of analgesia changed. 
When we treat patients we administer no analgesia initially. If the patient is expe-
riencing pain we give fentanyl citrate intravenously. Fentanyl citrate cannot be given 
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to high risk patients such as those with severe systemic lung disease, and fentanyl cit-
rate can cause side effects including bronchospasm, bradycardia, and nausea. 
Toxicity studies during EMLA application have shown that toxic serum concen-
trations ( 5 - 6 (Jg./ml.) are not reached even if EMLA is used for a long period. 
Covering a large area of skin with 2 gm. of EMLA for several hours yields a serum 
concentration of only 0.149 (Jg./ml4. 
We applied a 15-fold amount of cream, since dose-response studies showed that 
the dermal analgesia was increased after application of larger volumes and a more reli-
able analgesic effect was seen with higher dosage " . Also, for split skin-grafts, 30 
gm./100 cm1, proved to be effective and no systemic reactions were encountered ' \ 
We could establish no placebo effect of EMLA. In our pre-study control population 
51.4% of the patients needed fentanyl citrate during treatment, which is close to the 
53% rate of our later placebo group. Our results indicate that patients treated with 
EMLA experienced less pain than patients treated with the placebo cream. The skin is 
one of the most important areas for pain perception during ESWL treatment and 
pain depends largely on the aperture of the lithotripter used. However, although 
ESWL with piezoelectric shock wave generation is essentially painless '', the possible 
contribution of deep, organ-related pain cannot be ruled out. 'A 
In the patients who did not need fentanyl citrate (Figure 2) the pain scores at the 
end of treatment were equal. It is not likely that the anaesthetic effect of EMLA de-
creased with time in these patients since it has been demonstrated that the anaesthetic 
activity after cutaneous application is maintained for several hours 12 . Therefore, the 
EMLA-treated patients possibly experienced deep organ-related pain at the end of 
treatment. Organ-related pain might also explain why the percentage of patients 
needing fentanyl citrate was only 23% lower in the EMLA group, which was not sig-
nificant (p=o.32). However, of the EMLA patients who needed fentanyl citrate, the 
overall dose of fentanyl citrate was lower than that in the placebo group: 0.79 versus 
0.98 |Jg/kg. We applied the cream 1 hour before treatment. However, Juhlin recom-
mended a 90 to 120 minute application time to increase the anaesthetic effect I2 . 
Therefore, our results might improve with longer application time but treatment 
would be time-consuming, and a number of the patients would need intravenous fen-
tanyl citrate due to organ-related pain. 
In conclusion, EMLA does reduce the pain associated with ESWL. It is effective at 
cutaneous levels. EMLA should not be routinely applied in all patients undergoing 
ESWL. However, we consider EMLA a valuable anaesthetic alternative in ESWL, es-
pecially in patients in whom intravenous anaesthetics cannot be used. 
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Abstract 
Urolithiasis in children is uncommon in our geographical area. We treated 20 chil-
dren with urinary tract calculi by extracorporeal shock wave lithotripsy at our institu-
tion. Adjuvant procedures aimed at simultaneous correction of accompanying 
anatomic abnormality, metabolic disorder and urinary tract infection. After correc-
tion of those etiologic factors, 55 % of the children were stone-free after 3 months. 
ESWL can be effective in children only if the causes of their urolithiasis are treated si-
multaneously. 
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Introduction 
Extracorporeal shock wave lithotripsy (ESWL) was introduced in 1980 and has be-
come the preferred method of treatment for urinary stones '·*. 
Although its value in adults is widely accepted, few experiences of ESWL in chil-
dren have been reported, because only 2 to 3% of stone patients are children ' and the 
hazards of its use in children are not well defined. 
Since a Siemens Lithostar lithotripter was installed in our department in January 
1988, more than 2000 treatments have been performed. Our patients have included 
20 children less than 15 years old. 
This paper reports our experience with second-generation lithotripsy in children 
and discusses the role of ESWL in the treatment of urinary tract calculi in children. 
Material and methods 
Since January 1988, 20 children have been selected for ESWL. For each child, we took 
complete history and performed a physical examination, laboratory investigations 
and intravenous urography (IVU). There were 10 boys and 10 girls. Their average 
length was 136 cm. (range, 80 to 172 cm.) and their average weight was 34.2 kg. (range, 
10 to 57 kg.). Their average age was 9.8 years (range 8 months to 14 years). We treated 
the children with a second- generation Siemens Lithostar lithotripter according to the 
technique reported by Wilbert et al.4. We used straps to support the smaller children 
over the Lithostar table opening (Illustration 1); straps were not needed for children 
over 4 years old. Children with stones in the kidney and upper two-thirds of the 
ureter were treated while supine and children with stones in the lower one-third of 
the ureter were treated while prone. 
During treatment, the lung fields were protected from shocks with a polystyrene 
shield; the external genitals of boys were protected from x-rays with a lead shield. 
Most of the children (16) were treated under general anaesthesia. In four older 
children however (average age, 12 years), only intravenous fentanyl citrate (maximal 
dose, 0.1 mg.) proved to be sufficient. Shock waves were generated by an electromag-
netic discharge at 13.3 kV., and gradually increased to 16.3 kV. for children less than 8 
years old and to 18.1 kV. for older children. All the children had antibiotic prophylaxis 
or, if infection was present, received antibiotics according to the antibiogram for at 
least 5 days. Children were hospitalized for at least 1 day. After treatment ultrasono-
graphy of the kidney was used to detect renal haemorrhage or dilatation. All children 
were evaluated after 3 months with a plain x-ray picture. 
»5 
Illustration ι: Child supported by straps on the Lithostar table 
Results 
The main complaint of nine children was loin pain, that of five was hematuria and 
that of six was urinary tract infection. The causative microorganisms in the patients 
with urinary tract infections were Escherichia coli (in one), Klebsiella pneumoniae 
(in two) and Proteus Mirabilis (in three). 
Stones were discovered in three during followup after Anderson-Hynes plasty for a 
ureteropelvic junction stenosis. Table ι shows the locations of stones in all 20 patients. 
The average stone surface area in patients with single stones was 56 mm2. 
gé 
Table 1. stone localization 
Localization 
upper pole 
mid pole 
lower pole 
pelvis 
ureter 
bilateral calculi 
left 
1 
4 
4 
2 
right 
1 
1 
1 
3 
3 
2 
Table 2 summarizes possible etiologic factors for stone formation. 
Table 2 Etiological factors 
Previous history Anderson-Hynes plasty 3 
Immobilization 2 
Urinary infection 6 
Anatomic disorder Horseshoe kidney 
Medullary sponge kidney 
Reflux uropathy 
Bladder extrophy 
Metabolic disorder Primary hyperoxaluria Type I 
Cystmuria 
Screening for metabolic disorder revealed hypercalciuria (in one patient), hypocitra-
turia (one), cystinuria (three) and primary hyperoxaluria type I (one). In six children, 
no possible cause of nephro-urohthiasis could be detected. 
Auxiliary procedures before ESWL consisted of insertion of a nephrostomy 
catheter in two patients with obstructive ureteral stones and percutaneous stone de-
bulking in two others. 
An average of 3600 shocks were given in the first ESWL session (range 1600 to 
4000). There was no major morbidity. Complications after ESWL consisted of skin 
haematoma (in 13 patients) (illustration 2), prolonged hematuria (in five), fever of 
over 40 0C (in one) and a steinstrasse (in one), which evacuated spontaneously 3 days 
after ESWL treatment. Hospitalization lasted for an average of 2.4 days (range 1 to 6 
days). 
In none of the children was a renal haematoma of the treated kidney on the day 
after ESWL seen in ultrasonographic examination. After discharge from the hospital, 
four children had antibiotic treatment because of persistent urinary tract infection. 
The child with hypocitraturia received oral potassium citrate, and the child with hy-
percalciuria ( over 4 mg/kg per day) thiazide medication. 
Additional procedures after ESWL included rinsing through a nephrostomy to 
acidify the urine of one child with a Proteus infection. A second ESWL treatment had 
to be performed in five children because stones were not completely fragmented dur-
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ing the first session. In one child, who was treated for cloacal extrophy and had a kid­
ney in the pelvis and a trans uretero cutaneostomy, stone evacuation proved impossi­
ble because of the ureteral anatomy; operative correction was necessary. 
Of the 16 children with no metabolic disorder, π (69%) were completely free of 
stones and complaints after 3 months. The stone-free rate is comparable with the re­
sults of ESWL in adults. In four children, residual fragments of 2 to 5 mm were pre­
sent; two of the four were free of complaints, and two had persistent urinary tract in­
fections, for which antibiotics were given. Only one child (cloacal extrophy) had 
residual fragments larger than 5 mm. 
Figure 2: Skin haematoma after ESWL 
Stones from only six children were available for analysis. They were composed of cal­
cium oxalate (four patients), calcium oxalate/magnesium phosphate (one) and calci­
um oxalate phosphate (one). 
In the four children with metabolic disorders, the post-ESWL period was more com­
plicated. In the three patients with cystinuria, ESWL had resulted in partial fragmen­
tation of the stones. Auxiliary procedures consisted of percutaneous stone removal 
(PNL) (in two), rinsing with N-acetyl-cysteine diluted in sodium bicarbonate (three), 
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and oral administration of D-penicillamine (two), which was later replaced with Cap-
topril in one case. The child who did not receive penicillamine was given sodium cit-
rate to create a basic pH. All three children (average age n years) were advised to con-
sume a lot of fluid (more than 4 liters/day). After 3 months all three still had stones. 
In the child with primary hyperoxaluria type I, who had bilateral staghorn calculi, 
only one kidney had been cleared of stones after eight ESWL sessions, three PNL ses-
sions and one ureterorenoscopy in a period of a year. In the meantime, she was placed 
on oral pyridoxine medication and was advised to increase her fluid intake to at least 2 
liters/day. 
Discussion 
Urolithiasis in children is uncommon in our geographical area. Removal of calculi 
from children is indicated for any stone whose size and shape make spontaneous pas-
sage impossible and that causes symptoms of obstruction 3 (pain, recurrent urinary 
tract infection, or hematuria). Stone growth and deteriorating kidney-function form 
imperative reasons for therapy. 
ESWL has proved to be safe and effective in children with urolithiasis ' ·6 , 7 . The 
second-generation machines can be used without anaesthesia and often on an outpa-
tient basis 8. General anaesthesia however, is preferable in young children because 
during treatment the child should not move for at least one hour. Intravenous analge-
sia is sufficient only in selected older children. 
Children seem to pass fragments more easily than adults6, probably because of the 
elasticity of the walls of their urinary tracts and the relative width of the ureter in chil-
dren, compared with that in adults. Therefore, we believe that prophylactic stenting 
should not be done routinely, as previous reports suggested9. 
We noted neither post-ESWL renal haematoma nor signs of pulmonary contu-
sion, as described by Sigman et als; in our series, the lungs were always protected with 
polystyrene. We used lower kV. settings for the smaller children because we believe, 
like Nijman et alIO, that the magnitude of energy is more closely related to the risk of 
renal tissue damage than is the number of shocks. Evan et al reported that impair-
ment of renal function after ESWL depends on the number of shocks and is re-
versible, whereas the structural changes were not dose-dependent and were irre-
versible ". Renal changes also proved to depend on the rate of shock wave administra-
tion ". Therefore, cardial triggering, resulting in a higher frequency of shock wave ad-
ministration in order to reduce anaesthesia time, treatment time, and x-ray exposure 
time, should be avoided. 
There is still no clear consensus on the long-term effects of ESWL on bony struc-
tures. In a rat study Yeaman et al demonstrated that shock waves interfered with the 
growth of cartilaginous bone I3. Especially in the case of the immature skeleton of a 
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child treated in prone position for lower ureteral stone, ESWL might theoretically 
lead to growth retardation. 
There is no evidence that the ovaries of girls, treated in the prone position can be 
damaged if they are located in the shock wave path, as suggested by Vandeursen et 
al.'4. 
In our study, anatomic disorders were probably the cause of stone formation in 
eight children. It is important to recognize these factors and treat them simultaneous­
ly \ to decrease stasis and obstruction that could promote recurrent stone forma­
tion '5. Diamond et al. mentioned a likelihood of recurrent stone disease in 27% of 
patients with anatomic lesions Ів. 
Urinary infection is particularly important in any discussion of the causes of stone 
formation, especially when the organisms are Proteus, Pseudomonas, E.coli and 
Staphylococcus bacteria 3. In a 10-year review of stones in children, Noronha found 
that the most common symptoms were those associated with urinary tract infec­
tion ,7. ESWL can lead to fragmentation of an infection stone but eradication of the 
infection requires the elimination of both the stone and bacteria. Therefore, ESWL 
can be successful in these cases only if appropriate antibiotics are given during and 
after ESWL. Six of our patients presented with urinary tract infections and infection 
persisted with the residual fragments in two. Caches observed that a recurrent stone 
problem was invariably associated with Proteus infection l8; that indicates the impor­
tance of antibiotic treatment in this group. Antibiotic treatment after post-ESWL 
sterilization of the urine is appropriate but the recommended duration is controver­
sial l 6. In a study by Androulakis and associates, persistent infection had a 50% likeli­
hood of stone recurrence at 1 year '9. Therefore, a minimum of 1 year of antibiotic 
treatment followed by regular urine cultures seems reasonable ,6. 
Stone formation is due to a metabolic disorder in approximately 6% of cases3. None 
of our four children with a metabolic disorder became stone free after several applica­
tions of PNL and ESWL, despite fragmentation after ESWL and many adjuvant pro­
cedures. In the management of cystine stone disease, ESWL should be considered as 
an adjunctive procedure and should be used judiciously with other forms of thera­
py I9. Singer recently proposed an algorithm for treatment of cystine stones, but it is 
difficult to make absolute therapeutic recommendations 20. 
In addition to anatomic, infectious and metabolic etiology, paediatric urolithiasis can 
be caused by dehydration, overconsumption of dairy products and immobilization 2'. 
Recumbent stones occurred in our series in two children. Vahlensieck and Bastian 
recommended regular nourishment with a normal mixed diet and active physical ex­
ercise '. The diet should be adjusted according to stone composition to reduce recur­
rence. With calcium oxalate stones, the intake of milk should be restricted as should 
that of spinach, asparagus and rhubarb. With uric acid stones, food low in purine is 
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advisable and with phosphate stones, intake of dairy products and citrus fruits should 
be restricted '. 
Investigation of children with urolithiasis should include measurement of 24-hout 
urinary calcium, uric acid, and oxalate and determination of serum calcium, uric 
acid, electrolytes and creatinine ". Cystinuria has to be excluded. Thiazide diuretics 
can be given in cases of hypercalciuria, but care should be exercised in the paediatric 
use of these agents because of the possibility of associated hypokalemia, hyper-
glycemia, and hyperuricemia '5. Urine has to be cultured for microorganisms and 
many authors emphasize the importance of an IVU 3 '19 ·20 , by which the anatomy oí 
the urinary tract can be investigated. 
In conclusion, urolithiasis in children is often of complex origin, as was seen in our 
series. Most of our patients had more than one etiological factor. ESWL can be effec-
tive in the treatment of urolithiasis in children only if also accompanying metabolic, 
infectious, or anatomic disorders are treated, preferably simultaneously. 
91 
References 
1 Chaussy C, Schmiedt F, Jocham D, Brendel W, Forssmann, В and Walther V First clinical experi­
ence with extracorporally induced destruction of kidney stones by shock waves J Urol, 127 417, 
1982 
2 Lingeman JE, Newman D, MertzJHO, Mosbaugh PG, Steele RL·, Kahnoski RJ, Coury ТА and 
Woods JR Extracorporeal shock wave lithotripsy The Methodist Hospital of Indiana experience 
J Urol, 135 1134,1986 
3 Vahlensieck W and Bastian HP Clinical features and treatment of urinary calculi in childhood 
Eur Urol, 2 129,1976 
4 Wilbert, D M, Reichenberger H, Noske E, Riedmiller H, Aiken P, Hohenfelner R New genera­
tion shock wave lithotripsy J Urol, 138 663,1987 
5 Sigman M, I^udone VP, Jenkins AD, Howards SS, Riehle R jr, Keating MA and Walker RD 
Initial experience with extracorporeal shock wave lithotripsy in children J Urol, 138 839,1987 
6 Newman DM, Coury I , Lingeman JE, MertzJHO, Mosbaugh PG, Steele RE and Knapp PM 
Extracorporeal shockwave lithotripsy experience in children J Urol, 136 238,1986 
7 Minibcrg D T Extracorporeal shock wave lithompsy in children an overview J Endourol, Vol 3, 
no 4 385,1989 
8 Marberger M, Turk С and Steinkoglcr I Piezoelectric extracorporeal shock wave lithotripsy in chil­
dren J Urol, 142 349,1989 
9 Shepherd P, Thomas R and Harmon EP Urolithiasis in children innovations in management 
J Urol, 140 790,1988 
10 Nijman RJM, Ackaert K, Scholtmcijcr RJ, Lock TWTM, and Schroder FH Longterm results of 
extracorporeal shock wave lithotripsy 111 children J Urol, 142 609,1989 
11 Evan AP, Willis LR, Connors B, Saint R, McAteer A, Lingeman JE ESWL induces dose dependant 
changes in renal structure and function in the young minipig J Endourol Vol 4, suppl 1 abstr nr 
173,1990 
12 Delius M Bioeffectsof FSWL J Endourol Vol 4, suppl 1, state of the art, 1990 
13 Yeaman I D, Jerome CP and McCullough DL Fffects of shock waves on the structute and growth 
of the immature rat epiphysis J Urol, 141 670,1989 
14 Vandeursen H, Baert L Lithotripsy monotherapy for bladder stones with the second generation 
lithotripter J Urol 143 18,1990 
15 Sinno K, Boyce W H and Resnick M Childhood urolithiasis J Urol, 121 662,1979 
16 Diamond DA, Menon M, Lee PH, Rickwood ЛМК and Johnston JH Ethiological factors in pae-
diatnc stone recurrence J Urol, 142 606,1989 
17 NorohnaRFX, Gregory JG and Duke JJ Urolithiasis in children J Urol, 121 478,1979 
18 Gâches CGC, Gordon 1RS, Shore DF and Roberts JBM Urinary lithiasis in childhood in the 
Bristol clinical area Br J Urol, 47 109,1975 
19 Androulakakis PA, Barrat TM, Ransley PG and Williams DI Urinary calculi in children, A 5 to 15-
years follow-up with particular reference to recurrent and residual stones Br J Urol, 54 176,1982 
20 Singer A and Das S Cystinuna A review of the pathophysiology and management J Urol, 142 
669,1989 
21 Mazeman E, Wemeau L, Foissac MC , Riquet D and Tnboulct JP Urinary lithiasis in children, a 
review of 155 cases bur Urol, 5 157,1978 
22 Churchill DN, Maloney CM, Nolan R, Gault, M H andWinsorG Paediatnc urolithiasis in the 
1970s J Urol, 123 237,1980 
9* 
CHAPTER IO 
Efficacy of second generation lithotripters: a multicenter compara­
tive study of 2206ESWL treatments with the Siemens Lithostar, 
Dornier Hm4> WolfPiezolith 2300, Direx Tripter x-i, and 
Breakstone lithotripter. 
Bierkens, A.F.1, Hendrikx, A.J.M.1, de Kort, V.J.W.2, De Reyke, Т.э, Bruynen, C.A.H *, 
Bouvé, E.R.5, v.d. Beek, T.e. Vos, P.7, v. Berkel, H.1 
1 Radboud Academie Hospital, Nijmegen, the Netherlands 
2 Carolus Hospital, Den Bosch, the Netherlands 
3 Academie Medical Center, Amsterdam, the Netherlands 
4 Catharina Hospital, Eindhoven, the Netherlands 
5 Academic Hospital Rotterdam Dijkzigt, the Netherlands 
6 Academie Hospital Maastricht, The Netherlands 
7 Hospital de Lichtenberg, Amersfoort, The Netherlands 
Submitted to the Journal of Urology 
Abstract 
Extracorporeal shock wave lithotripsy (ESWL) has become the treatment of choice 
for urinary calculi. The good results of the first-generation Dornier HM3 lithotripter 
stimulated the development of second-generation machines. 
A multicenter trial is presented involving the Siemens Lithostar, Dornier HM4, 
Wolf Piezolith 2300, Direx Tripter X-i and Breakstone lithotripter to compare the 
therapeutic efficacy of second-generation machines. 
The five machines differed mainly in types of stones treated in relation to imaging 
system, use of anaesthesia, use of auxiliary procedures, and hospitalization, but overall 
success rates were similar. Treatment results were best for calculi less than 2 cm. in dia-
meter. None of the machines had a success rate comparable with that of the first-ge-
neration lithotripter. We conclude that second-generation ESWL is less effective than 
first-generation ESWL although second-generation ESWL is more convenient for 
patients. 
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Introduction 
Extracorporeal shock wave lithotripsy (ESWL) with the first commercially available 
lithotripter, the Dornier HM3, proved safe and effective for treatment of urolithia­
sis ,л . The good results stimulated the development of new lithotripters that use dif­
ferent means of shock wave generation and localization and with which treatment can 
often be performed on an outpatient basis and with less anaesthesia M . Although 
treatment results with the second-generation machines have been comparable with 
those with the gold-standard HM3 lithotripter, the newer machines are associated 
with a high retreatment rate 3 ' 5. 
In the Netherlands, the first lithotripter was installed in 1985. Today, 11 
lithotripters are in operation. A Dutch study group on ESWL, formed in 1988, which 
included representation of all different types of machines, considered it of interest to 
compare the therapeutic efficacy of the second-generation machines. It therefore 
began a prospective multicenter comparative trial. This article presents the results of a 
comparative study of the five types of second generation-lithotripters that are in oper­
ation in the Netherlands. 
Material and methods 
The multicenter trial was an open, prospective, uncontrolled, nonrandomized trial 
involving patients with urolithiasis who were treated in the Netherlands. The study 
was conducted from September 1989 to December 1990 and included patients with 
renal or ureteral calculi. 
The study participants were 17 ESWL centers that used the Siemens Lithostar 
(two centers), the Dornier HM4 (four), the Wolf Piezolith 2300 (seven), the Direx 
Tripter X-i (two) or the Breakstone lithotripter (two). Uniform study protocols, on 
which all relevant data on ESWL treatment could be recorded, were designed in co­
operation with all members of the Dutch Study Group on ESWL. After ESWL treat­
ment and followup, the protocols were forwarded to one center for computerized 
data analysis. Only patients who had been in followup for at least 3 months were eval­
uated. According to dayman, comparison of different lithotripters should be strati­
fied according to stone size, success percentage, application of auxiliary procedures, 
and retreatment rate. Clayman recently proposed an efficiency quotient for compar­
ing results with different lithotripters : 
100% χ % stonefree 
100% ist treatment + % retreatment + % auxiliary procedures 
We calculated the efficiency quotient for each machine. 
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Each treatment session was registered separately and 2206 ESWL sessions were per-
formed for a total of 2433 stones. A total of 1822 patients were treated: 1184 males 
(65%) and 638 (35%) females. Their average age was 51 years (range, 1 to 88 years). 
Treatment was performed on the left side in 1166 cases (53%) and on the right side in 
1040 cases (47%). Table 1 shows the numbers of patients, treatments, and stones in 
each of the five groups. Of all patients, 318 (17%) had more than one treatment. 
Table 1. Number of patients, treatments, and kidney and ureteral stones per machine 
Lithotri pter 
Siemens Lithostar 
Dormer HM4 
Wolf Piezolith 2300 
DirexTnpterX-1 
Breakstone 
Total 
No. pts. 
655 
306 
438 
355 
68 
1822 
No. treatments 
821 
338 
587 
388 
72 
2206 
Kidney stones No.(%) 
543(62) 
278(77) 
654 (95) 
360(83) 
63(81) 
1898 
Ureteral stones No.(%) 
333(38) 
83 (23) 
32(5) 
72(17) 
55(19) 
535 
Table 2a shows the average stone size, expressed as surface area, for each stone locale 
for each lithotripter. 
Table 2a. Average stone size ( mm surface area) 
Upper calyx 
Middle calyx 
Lower calyx 
Pelvis 
Staghorn 
Proximal ureter 
Middle ureter 
Distal ureter 
Siemens Lithostar 
99 
72 
72 
156 
696 
63 
49 
56 
Dormer HM4 
64 
62 
60 
110 
1855 
53 
63 
44 
Wolf Piezolith 
56 
49 
56 
110 
493 
56 
49 
36 
Direx Tnpter 
99 
90 
99 
150 
1320 
63 
56 
70 
Breakstone 
110 
58 
80 
306 
580 
88 
70 
— 
In table 2b, the number of stones per locale per machine is presented. 
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Table 2b. Number of stones per locale per machine 
Upper calyx 
Middle calyx 
Lower calyx 
Pelvis 
Staghorn 
Proximal ureter 
Middle ureter 
Distal 
Total 
Siemens Lithostar 
97 
78 
224 
134 
10 
102 
82 
149 
876 
Dormer HM4 
44 
32 
103 
94 
5 
39 
13 
31 
361 
Wolf Piezohth 
92 
115 
290 
138 
19 
26 
2 
4 
686 
DirexTripter 
49 
50 
149 
101 
11 
45 
20 
7 
432 
Breakstone 
8 
13 
26 
12 
4 
9 
6 
0 
78 
The average numbers of shocks, durations of treatment, x-ray exposure times, and 
energy levels are presented in table 3. Treatment time was relatively short,because it 
did not include pre-ESWL and post-ESWL care. 
Table 3 General data. a. excluding pre-ESWL and post-ESWL care 
Siemens 
No shocks 
kV(*=energy level) 
Average pulserete 
X-ray exposure time, mm 
Duration of treatment, mm a 
Lithostar 
3546 
13-18 
— 
22 
45 
Dorm ierHM4 
2019 
18-21 
— 
1 4 
56 
Wolf Piezohth 
2959 
3-4* 
3 
— 
39 
Direx Tripler 
1898 
16-20 
— 
48 
42 
Breakstone 
1287 
16 20 
— 
53 
31 
Of all treatments, 882 (40%) were performed on an outpatient basis. The percentages 
of outpatient treatments for the five machine were 56% (Siemens), 53% (Wolf), 11% 
(Dornier), 53% (Wolf) 12% (Direx) and 37% (Breakstone). 
Results 
As already indicated, 17 % of the patients needed more than one treatment. The retre-
atment rate was defined as the ratio of number of treatments to number of patients. 
The overall retreatment rate was 1.2. The retreatment rate with a given lithotripter de-
pended on stone locale and number (Table 4). 
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Table 4. Retreatment rates. *: not applicable. 
Retreatment rate (no. treatments/ no. patients) 
Siemens Lithostar Don 
Average 
Renal stones 
Ureteral stones 
Multiple stones 
Bilateral stones 
1.25 
1 1 
1 3 
24 
2.0 
HM4 
1.10 
1.1 
1.4 
3.0 
* 
Wolf Piezolith 
1.34 
1.3 
1.6 
1.8 
2.5 
Direx Tripter 
1.09 
1.0 
1.1 
1.5 
2.0 
Breakstone 
1.06 
1.1 
1.1 
* 
* 
Auxiliary procedures were required in 694, or 31%, of treatments (Table 5). 
Table 5. Treatments in which auxiliary procedures were required. 
Time 
Before ESWL 
During ESWL 
After ESWL 
Total 
Siemens Lithostar 
(n=821) 
169(21%) 
31 (4%) 
72 (9%) 
272 (33%) 
DornierHM4 
(n=338) 
55(16%) 
7 (2%) 
11(3%) 
73 (22%) 
WolfPiezohth 
(n=587) 
115(20%) 
30 (5%) 
24 (4%) 
169 (29)% 
Direx Tripter 
(n=388) 
84 (22%) 
43(11%) 
29 (7%) 
156(40%) 
Breakstone 
(n=72) 
11(15%) 
6 (8%) 
7 (10%) 
24 (33%) 
The types of procedures are listed in table 6. 
Table 6. Type of auxiliary procedures (n=694) and timing. 
Double-J stent 
Push-up 
Nephrostomy 
Ureterorenoscopy 
Percutaneous surgery 
Open operation 
Total 
Auxiliary procedure. 
Before ESWL 
332 (48%) 
6(1%) 
69(14%) 
-
-
-
434 (63%) 
No. % i 
During ESWL 
52 (8%) 
65 (9%) 
-
-
-
-
117(16%) 
auxiliary procedures 
After ESWL 
9 (1%) 
-
27 (4%) 
47 (7%) 
41 (6%) 
19(3%) 
143(21%) 
Of all auxiliary procedures, 63% were performed before ESWL treatment; they con-
sisted mostly of placement of Double-J stents. Only in 19% of the 344 midureteral 
and proximal ureteral calculi (Table 2b) retrograde manipulation "push and bang" 
was performed. Endourological or operative stone removal was eventually needed in 
only 107 patients (5.8%) after ESWL. The types of anaesthesia during ESWL are lis-
ted in table 7. 
Table 7 Percentage of treatments in which anaesthesia was used 
Siemens Lithostar 
Anaesthesia None 
Intravenous analgesia 
Intravenous sedation 
Sedation and analgesia 
Epidural anaesthesia 
General anaesthesia 
(n=821) 
38% 
48% 
1% 
7% 
4% 
2% 
Dorn 1er 
<n; 
HM4 
=338) 
90% 
6% 
4% 
— 
— 
— 
Wolf Piezohth 
(n=587) 
97% 
2% 
— 
— 
<1% 
<1% 
Direx Tripler 
(n=388) 
— 
3% 
42% 
11% 
44% 
Breakstone 
<n-72) 
8% 
— 
3% 
64% 
25% 
Minor complications occurred after treatment in 525 patients 2% (table 8). 
Table 8 Percentage of patients with minor complications. 
Proportion of patients with complications 
Siemens 1 
Complication skin effect 
Hematuria > 24 hours 
Renal colic needing analgesia 
Renal haematoma 
Fever > 38 S'C 
Arrhythmia 
Anaesthesia related problems 
Total 
Lithostar 
26% 
3% 
4% 
< 1 % 
3% 
4% 
— 
41% 
% 
Dornier HM4 
< 1 % 
< 1 % 
< 1 % 
— 
1 3% 
1.3% 
— 
3% 
Wolf Piezohth 
1 6% 
5% 
— 
2 3% 
< 1 % 
— 
9% 
DirexTripter 
2 5% 
2% 
2 8% 
— 
3 4% 
<1% 
3% 
13 9% 
Breakstone 
8% 
— 
2 9% 
— 
1 5% 
1 5% 
— 
13 9% 
Although most patients experienced transient hematuria directly after treatment, it 
lasted more than 24 hours in only 4% of the patients. The skin lesion in the Siemens 
group was temporary in all cases. 
Three months after treatment, the overall stone-free rate was 45%. The stone-free 
rates per lithotripter (see Figure 1) were 49% for the Siemens machine; 53%, Dornier; 
45%, Wolf; 50%, Direx; and 60%, Breakstone. The percentage varied among diffe-
rent ESWL centers: 48 - 53% for the Siemens machine; 44 - 63%, Dornier; 30 - 58%, 
Wolf; 47 - 68%, Direx; and 36 - 67%, Breakstone. 
Table shows the stone-free rates for stones of each locale. The success of treatment 
(Table 9) should be related to stonesize of each locale (Table 2a). 
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Table 9. Stone localisation and successrate (%) per lithotripter 
Siemens 
Stone locale Upper calyx 
Middle calyx 
Lower calyx 
Pelvis 
Proximal ureter 
Middle ureter 
Distal ureter 
Lithostar 
34% 
38% 
36% 
50% 
70% 
77% 
71% 
DornierHM4 
38% 
69% 
40% 
56% 
66% 
46% 
74% 
Wolf Piezolith 
52% 
43% 
48% 
64% 
62% 
100% 
75% 
Direx Tripler 
41% 
34% 
44% 
56% 
73% 
75% 
43% 
Breakstone 
25% 
69% 
46% 
42% 
89% 
83% 
— 
The efficiency quotients (according to Clayman) in our series are 31% for the Siemens 
machine; 38 %, Dornier; 28%, Wolf; 32%, Direx; and 43% for the Breakstone. 
The expectation of a stone-free result after ESWL is related to stone size. We categori-
zed stones into six subgroups (diameter). It can be seen in figure 1 that stonefree rates 
after one treatment decrease with increasing stone size. 
80 
60 
40 
) stonefree 
0-5 6-10 11-15 16-20 21-25 > 2 6 
stonesize mm. (diameter) 
• Siemens J Direx + Donner y Breakstone »Wolf 
100 % of patients 
Figure 1: 
Siemens dormer wolf direx breakstone 
• stonefree • fragments 2-5 mm 
• fragments < 2 mm 
Figure 2 
Patients with residual fragments were divided into three categories: with fragments 
less than 2 mm, 2-5 mm, and more than 5 mm in diameter. If the presence of residual 
fragments smaller than 5 mm in diameter, which can evacuate spontaneously is consi-
dered "successful", the success rate of each machine increases (Figure 2). 
Discussion 
To date, only a few comparative studies on the results of urinary-stone treatment with 
different lithotripters have been performed 7·8 '9 . Large comparative trials are hard to 
conduct, because many patients must be recruited and the multicenter setup is com-
plicated. However, we have been able to compare results with five lithotripters in 
2206 ESWL treatments. 
Comparative trials should refer to the results of the first-generation Dernier HM3 
lithotripter; stone-free percentages of 66% and 72% with the HM3 lithotripter were 
reported '^ . In our study, the overall results of second-generation lithotripsy (45% 
stone-free after 3 months) seem disappointing; even if the presence of fragments smal­
ler than 5 mm in diameter is considered as successful treatment, the success rate incre­
ases to only 75%, - still less than the 95% Lingeman et al. reported 2 . The stone-free 
rates per machine were similar (Figure 1), but lower than the results reported by ot­
hers ^9'1011'12. The importance of a multicenter setup is emphasized by the variation of 
success percentages among different ESWL centers and the relation of success to sto-
nesize (stones treated with the Dornier and Wolf machines were smaller than those 
treated with the other machines). 
The relatively low retreatment rate for renal calculi (Table 4) might be responsible 
for the low success percentage. Lingeman et al. achieved a 72% stonefree rate by per­
forming 1416 treatments in 982 patients г . According to our definition, that would 
imply a retreatment rate of 1.44. In our series the success percentage of ESWL for ure­
teral calculi is higher than that for renal calculi (table 9 ); that can be explained by the 
higher retreatment rate. The problem of retained renal fragments should be conside­
red. Treatment success implies not only stonefree patients, but also reduction of com­
plaints. Asymptomatic retained fragments should not be treated (although some aut­
hors state that retreatment with second-generation machines has become a simple 
outpatient procedure and can be used liberally3 ). ESWL still has a potential for renal 
damage; despite the development of new generation machines, the potential for rela­
ted side effects is not yet well understood l3''4 . Therefore, we believe that ESWL 
should be performed with caution, regardless of the type of machine used, and that 
asymptomatic fragments should be left alone. 
Stone size has a clear impact on treatment outcome. Lingeman et al. stated that 
ESWL should be the preferred method of treatment for symptomatic calculi less than 
2 cm in diameter and percutaneous treatment should be considered for larger stones 
because the morbidity associated with ESWL for large stones appears to be more clo­
sely comparable to percutaneous techniques 2 . Others reported good treatment re­
sults of ESWL monotherapy for staghorn calculi , 5. Marberger et al. found that only 
50% of patients with calculi larger than 2.5 cm were stonefree after 3 treatments ' . 
Siemens Lithostar lithotripsy of such calculi resulted in only a 46% stonefree rate ", 
whereas Tailly, using the Dornier HM4, recently advocated staged ESWL treatment 
for large calculi 9. As can be seen from figure 1, the best treatment results were obtai­
ned with stones less than 1 cm in diameter. There were no major differences in success 
percentage between the five machines (Figure 2) although results for large stones were 
poor with the Wolf machine. Therefore, we believe that ESWL with second-genera­
tion lithotripters should be restricted to stones less than 2 cm in diameter. 
Hospitalization lasted an average of 3 daysІЛ , with the Dornier HM3. Although 
ΙΟΙ 
outpatient treatment is an important feature of second-generation ESWL, only 40% 
of our patients were treated as outpatients. The difference between the several machi-
nes in percentage of patients treated as outpatients (range, 12 - 56%) needs to be ex-
plained. With the introduction of mobile lithotripters, as at all four Dornier centers 
and five of seven Wolf centers, logistics often required hospitalization for one night in 
many patients. The need for anaesthesia of many patients with the Direx and 
Breakstone machines also warranted hospitalization and more intensive post-ESWL 
care. In both Siemens centers, with increased experience, outpatient treatment is now 
the method of choice in more than 80% of cases. 
General anaesthesia is preferred for treatment with the Dornier HM3 '^ 2. 
Modifications and technical developments of second-generation lithotripters have re-
sulted in a reduction of the need for anaesthesia. Piezoelectric ESWL (EPL) is essen-
tially painless ', which is in accordance with our results (97% no anaesthesia), and 
90% of the treatments with the Dornier HM4 could be performed without anaesthe-
sia in our study. Many of the few patients who need general anaesthesia are children, 
but treatment with the Direx and Breakstone machine requires general or epidural 
anaesthesia in many cases. That disadvantage is compensated for by the relatively 
high success rate and low re-treatment rate (Table 4, Figure 1). In contrast, painless 
EPL has a relatively low success rate. 
Drach at al. reported that 14% of patients required additional procedures after 
ESWL with the Dornier HM3 '. We found that auxiliary procedures were required 
before 20% of ESWL treatments (Table 5) 
Ureteral calculi have been subjected to several methods of treatment, such as retro-
grade manipulation or bypassing a stent. In the Wolf Piezolith group, only a small 
proportion of the patients treated (5%) had ureteral calculi, whereas the percentage 
varied from 17% to 38% with the fluoroscopic guided machines (Table 1). Although 
some authors claim effective EPL for ureteral calculi3 , Neerhut et al. stated that the 
main disadvantage of ultrasonography is that stones in the upper and middle ureter 
can be more difficult to locate and often require primary dislodgementl6. In our se-
ries, 68% of the ureteral calculi treated with EPL were pushed back before ESWL tre-
atment. Especially because other lithotripters produce good results for in situ ESWL 
of ureteral calculi, ureteral calculi should be treated with fluoroscopically guided ma-
chines. 
Other ureteral calculi were subjected to ureterorenoscopy, mainly in the Siemens 
group, in which a relatively high percentage of lower ureteral stones was treated. A 
high percentage of patients had a Double-J stent before ESWL, especially in the 
Siemens and Wolf groups. The Siemens machines are installed in referral centers; pa-
tients elsewhere often have to wait for treatment and were given Double-J stents by 
the referring urologists in case of obstructive ureteral calculi. In the Wolf group, 
Double-J stents were used especially after retrograde manipulation of ureteral calculi 
and in cases of large calculi to avoid post-ESWL obstruction. 
It is generally accepted in the Netherlands that ESWL should and can be perfor-
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formed with the least auxiliary procedures necessary; that implies in situ ESWL for 
ureteral calculi and ESWL for large calculi without prophylactic stenting. 
Nevertheless, in case of obstructive ureteral calculi with fever, drainage should be per-
formed, either through nephrostomy or through use of a Double-J stent. Auxiliary 
procedures are more a consequence of the type of stone to be treated than an option 
chosen before consideration of treatment. 
Complications in our series occurred in few patients. We noted with interest that 
the complication rates in the Wolf and Dornier groups were very low, which favors 
these machines. In the Direx group, a small percentage had problems related to anaes-
thesia. 
A few words on the localization systems of the second-generation machines are in 
order. Although Bowsher et al. stated that ultrasonographic localization is as effective 
as x-ray localization 5 , we believe that fluoroscopic imaging, with its short learning 
curve, is preferable, because stones in all locations can be visualized with it. However, 
x-ray exposure is avoided with ultrasonography, and that constitutes a major advanta-
ge over the Direx and Breakstone machine, with which x-ray exposure lasted at least 
twice as long as with the Siemens and Dornier machines (Table 3), because of the 
more difficult handling of the C-bow. An integrated combination of fluoroscopy and 
ultrasound is the preferred localisation system, because 'easy' stones can be localised 
and monitored by ultrasound and for 'difficult' stones, e.g. ureteral stones, fluorosco-
py can be used. 
The second-generation lithotripters are comparable in effectiveness with oneanot-
her (Figure 2), but they are not as effective as the first-generation Dornier HM3, as 
was demonstrated by the efficiency quotients. With the Dornier HM3, the efficiency 
quotient varied from 54% ' to 58% 2 . 
Although the excellent results of the HM3 could not be reproduced, we believe 
that second-generation lithotripters represent an improvement in ESWL because 
they permit less need for anaesthesia, less need for hospitalization and less need for 
auxiliary procedures. 
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Summary and conclusions 
i°5 

Summary 
Urolithiasis is the third most common affliction of the urinary tract and seems to 
have occurred since the beginning of mankind. Until the 1980s, open surgery remai-
ned the preferred treatment for urinary calculi. 
The introduction of Extracorporeal Shockwave Lithotripsy (ESWL) constituted a 
major breakthrough in the management of urolithiasis. 
The technical principles of shock waves and different methods of shock wave ge-
neration are discussed in the introduction of this thesis. 
Chapter 3 describes the results of ESWL treatment for large renal calculi (stone-
burden of more than 200 mm2 ). 
We evaluated in a randomized trial the benefits of ureteral stents, inserted pro-
phylactically before ESWL treatment, and found that stents were associated with a 
clear morbidity. The complication rate in the stented patients was comparable to that 
of in situ treated patients. The stone-free results after three months of ESWL with or 
without stents did not differ significantly (44% vs 35%). We conclude, that large cal-
culi should be treated in situ. Since the stone-free results in both groups were relative-
ly poor, percutaneous debulking should be considered before ESWL for large renal 
calculi. 
In chapter 4 we evaluated the results of ESWL in 38 patients with symptomatic 
renal calculi of less than 5 mm in diameter. We found that only 32% of the patients 
were both free of stones and complaints, three months after ESWL. Nineteen of the 
38 patients became stone-free, but complaints persisted in seven of them; obviously 
the stones had not been the cause of their complaints. In contrast, eight of 19 patients 
with residual stones were free of complaints, another indication of lack of relation be-
tween the presence of small stones and complaints. We therefore conclude that one 
should be reluctant in treating small renal calculi. 
ESWL is contraindicated in cases of obstruction below the calculus, which is the 
case in calyceal diverticula calculi. However, there are authors who advocate ESWL 
for such stones. In chapter 5 we evaluated the results of ESWL treatment for calyceal 
diverticula calculi and compared them with the results obtained by percutaneous tre-
atment (PNL). Of the 15 patients treated by the ESWL only 2 became stone-free, 
whereas 10 of 13 patients treated by PNL became stonefree. However, PNL was asso-
ciated with a clear morbidity. In the ESWL group, seven of the 13 patients (54%) with 
residual stones were free of complaints. We therefore conclude that one should be re-
luctant to treat calyceal diverticula calculi. If treatment is indicated, ESWL is the first 
choice, but will probably only lead to relief of symptoms. If ESWL fails, percutaneous 
treatment should be performed and its morbidity should be accepted. 
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For ESWL treatment of calculi in the upper two thirds of the ureter, three treat-
ment options are suggested: in situ ESWL, ESWL after retrograde manipulation of 
the stone into the renal collecting system, and ESWL with a ureteral stent beside the 
stone. In a randomized trial of 47 patients with calculi in the upper two thirds of the 
ureter, in which the results of in situ ESWL and ESWL after retrograde manipulation 
were compared (Chapter 6), we found that 91% of the patients treated in situ became 
stone-free after 3 months, whereas all patients in whom the stone had been pushed 
back into the renal pelvis became stone-free. However, the retrograde manipulation 
succeeded in only 37.5% of the patients and all men needed epidural anaesthesia for 
this procedure. In cases of dilatation at the treated site, the retrograde manipulation 
seemed to fail more often. We therefore conclude, that in situ ESWL is the preferred 
method of treatment for stones in the upper two-thirds of the ureter. 
In the treatment of lower ureteral calculi (Chapter 7) we demonstrated in a rando-
mized trial, that in cases of hydronephrosis, the results of ESWL improved, if a loop 
catheter was positioned around the stone: 73% of the patients became stone-free, 
compared to only 20% of the patients treated in situ. However, if there was no dilata-
tion at the treated site, in situ ESWL resulted in a stone-free rate of 86%, whereas all 
patients treated with a loopcatheter around the stone became stone-free after ESWL. 
We conclude that the use of a loop catheter is justified in the treatment of lower ure-
teral calculi in cases of dilatation, despite the need for epidural anaesthesia in men in 
whom this procedure is performed. If dilatation is absent, in situ ESWL can be per-
formed. 
With the introduction of second-generation lithotripters, the need for general or 
epidural anaesthesia in ESWL treatment has decreased. Of our population more than 
half of the patients needed intravenous analgesia (fentanyl citrate) during ESWL tre-
atment. Fentanyl citrate can have severe side effects. In chapter 8 we studied the the-
rapeutic efficacy of a local anaesthetic cream (EMLA). Our results of this double 
blind randomized trial indicate, that patients treated with EMLA experienced less 
pain during ESWL treatment than patients treated with a placebo cream. We also 
found that the percentage of patients needing intravenous analgesia, decreased from 
53 to 23 if EMLA cream was applied. Longer application time (more than 1 hour) 
might improve our results, but treatment would be time consuming and a number of 
patients would need intravenous analgesia because of deep organ related pain. EMLA 
is effective in decreasing cutaneous related pain during ESWL treatment. We consi-
der EMLA a valuable anaesthetic alternative in ESWL. It should not be routinely ap-
plied, but can be useful in patients in whom intravenous anaesthetics cannot be used. 
ESWL is the treatment of choice for urinary calculi. Of our population of child-
ren, 55% were stone-free, 3 months after ESWL treatment. However, especially in 
children attention should be paid to accompanying etiological factors such as anato-
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anatomie, metabolic and infectious disorders. Especially since there is still no consen-
sus on the long term effects of shock waves on the renal tissue, ESWL in children 
should be used with caution. Chapter 9 describes our results of ESWL in children 
with special emphasis on the treatment of etiological factors in this group of patients. 
The good results of the first generation lithotripter Dornier HM3 resulted in the 
development of new second generation machines. So far, no large comparative trial 
on second generation machines has been reported. In a multicenter trial of 2206 
ESWL treatments, in which the Siemens Lithostar, Dornier HM4, Wolf Piezolith 
2300 , Direx Tripter X-i and Breakstone machine were compared (Chapter 10), we 
found little differences in success percentages between the machines. No second ge-
neration lithotripter seemed as effective as the Dornier HM3. The best treatment re-
sults for second generation lithotripters are obtained, if treatment is limited to stones 
of less than 2 cm in diameter. Although second-generation ESWL is less effective than 
first-generation ESW^L, we conclude that it is to be considered an improvement in 
ESWL treatment, since the use of anaesthesia, the duration of hospitalisation, and the 
complication rate are decreased. 
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Samenvatting en conclusies 

Samenvatting 
Het optreden van nierstenen is op twee na de meest voorkomende aandoening van de 
urinewegen en schijnt sinds het begin der mensheid bekend te zijn. 
Tot 1980 was open chirurgie de aangewezen behandeling voor stenen in de urine-
wegen. Met de introductie van Extracorporeal Shock Wave lithotripsy (ESWL) heeft 
zich het laatste decennium een revolutionaire doorbraak voorgedaan in de behande-
ling van nierstenen. 
De technische principes en verschillende methodes van het opwekken van schok-
golven worden besproken in de introductie van dit proefschrift. 
Hoofdstuk 3 beschrijft de resultaten van ESWL behandeling van grote nierstenen 
(steenoppervlak meer dan zoo mm2 ). 
Wij evalueerden hierbij in een gerandomiseerde studie de voordelen van het pro-
fylactisch plaatsen van Double-J catheters vóór de ESWL behandeling. We vonden 
dat Double-J catheters met een duidelijke morbiditeit geassocieerd waren en dat de 
complicaties na ESWL behandeling vergelijkbaar waren met die welke gevonden wer-
den bij in situ behandeling van dergelijke stenen. Tussen beide groepen werd geen sig-
nificant verschil gevonden in het percentage steenvrije patiënten (44 versus 35). Wij 
concluderen, dat grote nierstenen in situ behandeld dienen te worden. Aangezien het 
percentage steenvrije patiënten relatief laag te noemen was, dient percutané 'steende-
bulking' voorafgaand aan ESWL voor grote nierstenen overwogen te worden. 
Stenen met een diameter van minder dan 5 mm kunnen spontaan geloosd wor-
den. In hoofdstuk 4 worden de resultaten geëvalueerd van ESWL bij 38 patiënten met 
symptomatische nierstenen met een diameter van minder dan 5 mm. We vonden dat 
drie maanden na ESWL behandeling slecht 32% van de patiënten zowel steenvrij als 
klachtenvrij was. Slechts 19 van de 38 patiënten waren steenvrij. Echter, bij 7 van hen 
bleven de klachten bestaan; waarschijnlijk was de steen niet de oorzaak van de klach-
ten geweest. Van de 19 patiënten met reststenen hadden er 8 geen klachten meer, het-
geen ook geduid kan worden als een gebrek aan relatie tussen de aanwezigheid van 
kleine stenen en klachten. Wij concluderen dan ook, dat terughoudendheid moet 
worden betracht in de behandeling van kleine nierstenen. 
ESWL is gecontraindiceerd in die gevallen waarbij er obstructie onder de steen is, 
hetgeen het geval is bij kelkdivertikelstenen. Desalniettemin adviseren sommige au-
teurs toch ESWL voor dergelijke stenen. In hoofdstuk 5 beschrijven wij de resultaten 
van ESWL voor kelkdivertikelstenen en vergelijken die met de resultaten van percuta-
né chirurgie (PNL). In de ESWL groep (n=i5) waren slechts 2 patiënten steenvrij na 
de behandeling, terwijl er 10 van de 13 patiënten die middels PNL behandeld waren 
steenvrij waren. PNL ging echter gepaard met een hoge morbiditeit. Anderzijds 
waren 7 van de 13 patiënten met reststenen in de ESWL groep vrij van klachten 
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(54%)· Wij concluderen derhalve, dat men terughoudend dient te zijn in de behande-
ling van kelkdivertikelstenen. 
Indien behandeling is geïndiceerd is ESWL de eerste keuze, al zal dit slechts leiden 
tot het verdwijnen van klachten. Wanneer ESWL faalt kan percutané behandeling te 
worden uitgevoerd en zal de ermee gepaard gaande morbiditeit geaccepteerd moeten 
worden. 
ESWL behandeling van hoge ureterstenen kan op verschillende manieren geschie-
den: in situ ESWL, ESWL nadat de steen retrograad in het nierbekken is gemanipu-
leerd, en ESWL met een catheter langs de steen. 
In een gerandomiseerde studie van 47 patiënten met stenen in het bovenste 
twee/derde van de ureter worden de behandelingsresultaten beschreven van in situ 
ESWL en ESWL nadat gepoogd was de steen retrograad te manipuleren (Hoofdstuk 
6). We vonden dat na drie maanden, 91% van de patiënten, die in situ waren behan-
deld, steenvrij was terwijl alle patiënten, bij wie de steen met succes in het nierbekken 
was gemanipuleerd, na 3 maanden steenvrij waren. De retrograde manipulatie slaagde 
echter slechts bij 37.5% van de patiënten en vereiste epiduraal anesthesie bij alle man-
nen die voor deze procedure waren gerandomiseerd. Dilatatie aan de behandelde 
zijde zou het retrograad manipuleren kunnen bemoeilijken. Wij concluderen dan ook 
dat in situ ESWL de voorkeur verdient bij de behandeling van ureterstenen in het 
proximale twee/derde gedeelte van de ureter. 
Voor de behandelingen van ureterstenen in het distale een/derde van de ureter 
(Hoofdstuk 7)vonden wij in een gerandomiseerde studie dat de behandelingsresulta-
ten van ESWL verbeterden, wanneer in gevallen van dilatatie aan de behandelde zijde 
een luscatheter rond de steen geplaatst was: 73% van de patiënten raakte steenvrij ter-
wijl dit percentage slechts 20 bedroeg voor patiënten die in sim behandeld waren. Bij 
afwezigheid van dilatatie was 86% van de in situ behandelde patiënten steenvrij, ter-
wijl dit percentage 100 bedroeg indien een luscatheter rond de steen geplaatst was. 
Wij concluderen dan ook, dat het gebruik van een luscatheter gerechtvaardigd is in 
gevallen van dilatatie aan de behandelde zijde, hoewel dit epidurale anesthesie bij 
mannen vereist. Bij afwezigheid van dilatatie kan in situ ESWL worden uitgevoerd. 
Met de introductie van tweede generatie niersteenvergruizers is de toepassing van 
algehele of epidurale anesthesie bij ESWL afgenomen. Van onze padentenpopulatie 
had meer dan de helft van de patiënten intraveneuze analgesie (Fentanyl) nodig. 
Fentanyl kan ernstige bijwerkingen hebben. In hoofdstuk 8 bestudeerden we het 
therapeutisch effect van een locaal anestheticum (EMLA). De resultaten van deze 
dubbel-blind gerandomiseerde studie toonden aan, dat patiënten, die met EMLA 
werden behandeld, minder pijn ervaarden tijdens ESWL dan patiënten, die met een 
placebo behandeld waren. We vonden tevens dat het percentage patiënten, dat intra-
veneuze analgesie nodig had tijdens ESWL, van 53 naar 23 afnam, indien EMLA aan-
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aangebracht was. Een langere inwerktijd (bijv. meer dan ι uur) zou onze resultaten 
mogelijkerwijs kunnen verbeteren, maar de behandeling zou zeer tijdsintensief wor­
den en een aantal patiënten zou alsnog intraveneuze anesthesie nodig hebben wegens 
diepe, orgaan-gerelateerde pijn. Toch beschouwen wij EMLA als een waardevol alter-
natiefvoor pijnstilling bij ESWL aangezien de cutané pijn erdoor wordt gereduceerd. 
Het dient echter niet routinematig gebruikt te worden, maar kan zinvol zijn bij pa-
tienten bij wie intraveneuze pijnstilling is gecontraindiceerd. 
ESWL is de aangewezen methode voor de behandeling van nierstenen. In onze 
populatie van kinderen was 55% na drie maanden steenvrij. Speciaal bij kinderen 
dient aandacht geschonken te worden aan bijkomende etiologische factoren zoals 
anatomische, metabole en infectieuze aandoeningen. Aangezien er tot op heden nog 
geen duidelijke consensus is betreffende de effecten van schokgolven op nierweefsel 
dient voorzichtigheid betracht te worden bij ESWL bij kinderen. Hoofdstuk 9 be-
schrijft onze resultaten van ESWL bij kinderen waarbij speciaal stilgestaan wordt bij 
de enologie en behandeling van nierstenen in deze patiëntengroep. 
De goede resultaten van ESWL behandeling met de eerste generatie niersteenver-
gruizer van het type Dornier HM3 leidde tot de ontwikkeling van nieuwe tweede ge-
neratie niersteenvergruizers. Tot dusver zijn er nog geen grote vergelijkende studies 
van tweede generatie niersteenvergruizers uitgevoerd. In een multicenter studie wor-
den de resultaten beschreven van 2206 ESWL behandelingen beschreven betreffende 
de Siemens Lithostar, Dornier HM4, Wolf Piezolith 2300, Direx Tripter en 
Breakstone niersteenvergruizer (Hoofdstuk 10). We vonden weinig onderling verschil 
in succespercentage van de verschillende machines. Geen enkele tweede generatie 
niersteenvergruizer was even effectief als de Dornier HM3. Hoewel tweede generatie 
niersteenvergruizing minder effectief is concluderen wij dat het een vooruitgang be-
treft in niersteenvergruizing aangezien het gebruik van anesthesie, de duur van hospi-
talisade en het optreden van complicaties zijn verminderd. De beste behandelings-
resultaten werden voor ESWL bereikt met de behandeling van stenen met een diame-
ter van minder dan 2 cm. 
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STELLINGEN 
behorende bij het proefschrift 
Extracorporeal 
Shock Wave Lithotripsy 
For Urinary Calculi 
A.F. BIERKENS 
Nijmegen 24 oktober 1991 
1 
Stenen in het proximale twee/derde van de ureter dienen in situ vergruisd te wor-
den. Indien na behandeling steenevacuatie uitblijft of de steen-configuratie niet 
verandert zal, speciaal in gevallen van nierdilatatie, een invasievere behandeling 
uitgevoerd dienen te worden. (Ditproefichrifi) 
2 
De plaatsing van Double-J stents dient bij vergruizing van grote nierstenen achter-
wege gelaten te worden, aangezien deze methode de morbiditeit van vergruizing 
niet reduceert, eigen complicaties met zich meebrengt en niet bijdraagt aan succes-
volle steenpassage na vergruizing. (Ditproefichrifi) 
3 
Niersteenvergruizing bij kinderen leidt slechts tot succes, wanneer men tevens de 
bijkomende anatomische, infectieuze en/of metabole aandoeningen in de behan-
deling betrekt. (Ditproefichrifi) 
4 
Bij de vergruizing van distale ureterstenen leidt, in gevallen van hydronefrose, het 
plaatsen van een luscatheter rond de steen tot een beter behandelingsresultaat. 
(Dit proefichrifi) 
5 
Bij de behandeling van galblaasstenen verdient chirurgische interventie de voor-
keur boven vergruizing. 
6 
In geval van niercclcarcinoom biedt, in aanwezigheid van een solitaire métastase, 
nefrectomie en verwijdering van de métastase de beste levensverwachting. 
7 
Neo-adjuvante hormonale voor-behandeling van T3M0N0 prostaatcarcinoom 
leidt tot volumereductie van de prostaat en vereenvoudigt de radicale prostatecto-
mie. 
S 
Bij de behandeling van de benige prostaat-hypertrofie middels TURP, TUMT of 
TULIP wordt voornamelijk een subjectieve verbetering van de klachten bereikt. 
9 
De mannen zouden minder tobben over erectiezwakte indien zij beter naar hun 
vrouwen zouden luisteren. 
10 
Voor de artsen geldt nog steeds het oude adagium van Hippocrates, dat de patiën-
ten hun beste leermeesters zijn. 
11 
Het vele dat men tegenwoordig van de gezondheidskunde moet doen en laten om 
gezond te blijven, bevestigt de stelling van Zola, dat leven slecht is voor de gezond-
heid. (I.K. ZoL·: De medische macht. Boom, Meppel 1973) 
12 
Bij niersteenvergruizing met schokgolven is er letterlijk sprake van de steen des 
aanstoots. 



